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ABSTRACT 
Studying insomnia in aging populations is critical since the risk of insomnia 
increases with age, and insomnia is associated with numerous negative outcomes, such as 
cognitive impairments and co-occurring psychiatric disorders. The Vietnam Era Twin 
Study of Aging (VETSA) is a longitudinal study that investigates the relative 
contributions of genes and the environment to age-related changes in a broad range of 
characteristics. This thesis examined VETSA participants (n=l237; mean age=55.6) and 
utilized classic twin analyses, neuropsychological assessments, hormone, genotype, and 
structural MRI data to explore the etiology of insomnia, the relationship between 
insomnia and depression, and the mechanisms through which insomnia may influence 
cognitive decline. 
Results demonstrate that genetic factors are responsible for approximately 34% of 
the variation in individual differences in insomnia while non-shared environmental 
influences are responsible for the remaining 66%; shared family environmental 
influences are negligible. This study was the first investigation of the extent to which 
lV 
symptoms of insomnia and depression share a single genetic liability or independent 
liabilities, as these disorders often co-occur. Results demonstrate that much ofthe 
genetic influence on insomnia is also associated with depression, suggesting that the 
comorbidity between these disorders reflects shared genetic effects. There is an 
association between insomnia and poorer performance on tests of general cognitive 
ability, visual spatial processing and memory, short term memory, and working memory. 
After adjusting for depression, insomnia was significantly related to visual spatial 
processing and memory, suggesting that treating insomnia might be a successful 
intervention for individuals who demonstrate visual spatial memory and processing 
impairments. To explore mechanisms through which insomnia influences cognitive 
decline, cortisol, hippocampal volume, and the apoE genotype were examined. Insomnia 
was significantly related to smaller hippocampal volume; there was no association 
between insomnia and cortisol levels. ApoE genotype is related to deficits in recovering 
from neuronal insult, but insomnia did not differentially impact cognition based on apoE 
genotype. However, trends towards interactions were observed, particularly on memory 
domains. These findings have implications for the treatment of insomnia and depression 
and may inform prevention and intervention techniques aimed at cognitive preservation, 
which is of central importance in successful aging. 
v 
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CHAPTER ONE: General Introduction 
Overview 
The major goal of the Vietnam Era Twin Study of Aging (VETSA) is to 
investigate the relative contributions of genes and the environment to age-related changes 
in a broad range of characteristics. VETSA is a large-scale longitudinal study that 
follows male twin pairs from middle to late age and focuses on the genetic and 
environmental contributions to the cognitive processes over time. The study employs a 
multi-trait multi-method approach, in which factors such as brain structures, health, 
personality, and psychosocial functioning, are assessed in relation to cognitive aging. 
This dissertation utilizes VETSA data collected at baseline and focuses on two outcomes 
known to change with age: the development of insomnia and impairments in cognitive 
functioning. 
Clinical insomnia is characterized by difficulty initiating and maintaining sleep, 
early morning awakenings, and non-restorative sleep and is associated with daytime 
impairment or distress. The Diagnostic and Statistical Manual of Mental Disorders, 
Fourth Edition, Text Revision (DSM-IV-TR) (1994) requires that symptoms must persist 
for at least one month and cannot be attributed to the presence of another sleep disorder, 
medical condition, or physiological effect of a substance. The DSM includes two types 
of insomnia, primary and secondary. Primary insomnia occurs when there is no current 
or past psychiatric disorder or the course of insomnia is independent from the course of 
the mental disorder, and secondary insomnia occurs when sleep problems coincide with 
the onset and course of another DSM disorder but are significant enough to warrant 
separate clinical attention. 
The reported prevalence rates of insomnia are high, yet rates vary based on how 
insomnia is defined, which is an enormous limitation of extant epidemiological studies. 
Variation in prevalence rates based on stringency of definition range from 33% when 
assessing solely for nocturnal sleep disturbances, 9-15% when including the presence of 
daytime impairment, 8-18% when including sleep dissatisfaction, to 6% when using full 
DSM diagnostic criteria for insomnia (Ohayon, 2002). More recent reports demonstrate 
that approximately 6-10% of adults meet diagnostic criteria for an insomnia disorder at 
any given time (Morin et al., 2009; Roth & Roehrs, 2003). 
Research has consistently found that the prevalence of insomnia and associated 
sleep problems increases with age (Morphy, Dunn, Lewis, Boardman, & Croft, 2007; 
Rosekind, 1992; Roth & Roehrs, 2003). One study examined women ages 35-64 and 
found that of 30 general symptoms included in the Complaint Score subscale of the 
Gothenburg Quality of Life Instrument, insomnia was one ofthe five symptoms that 
significantly increased With age (Bardel, Wallander, Wedel, & Svardsudd, 2009). The 
remaining 25 symptoms either decreased or remained stable. The rate of insomnia has 
also been found to significantly increase among individuals over the age of 65. While 
35% to 50% of individuals age 65 and older report to have insomnia, the prevalence of 
insomnia among individuals ages 20 to 30 is only 9% (Lichstein, 2004). 
2 
Research has also indicated that while younger people tend to have trouble falling 
asleep, older people have difficulty maintaining sleep (Rosekind, 1992). Recent studies 
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have found that difficulty resuming/maintaining sleep is related to poor daytime 
functioning (i.e., fatigue, daytime sleepiness, affective tone, and difficulty completing 
daily tasks) to a greater extent than are other insomnia symptoms, such as difficulty . 
initiating sleep (Nebes, Buysse, Halligan, Houck, & Monk, 2009; Ohayon, 2009). 
Furthermore, insomnia is associated with numerous health outcomes such as cognitive 
impairments, mental illness, and physical health problems, including compromised 
immunity (Taylor et al., 2007). Higher prevalence rates of insomnia in the elderly, 
coupled with symptoms characterized by difficulty maintaining sleep and with associated 
negative health outcomes, leads to a significant public health concern regarding sleep 
problems in aging populations. 
Specific Aims of This Dissertation 
The main objective of this dissertation is to develop a greater understanding of 
insomnia and comorbid disorders (i.e., depression) using classic twin methods and to 
explore the complex relation between insomnia and cognitive functioning. There are four 
specific aims examined in this dissertation, and each chapter will address an aim. The 
background, methods, and results of the four aims are described in detail in chapters two, 
three, four, and five. Each chapter concludes with a discussion specific to the study 
findings . In chapter six, a comprehensive discussion is presented that serves to integrate 
conclusions from the four studies. 
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Specific Aim 1: The genetic and environmental influences on symptoms of insomnia 
(Chapter 2) 
Rationale. While several twin studies have examined the extent to which genes 
and the environment contribute to the variability of symptoms of insomnia, most of these 
studies used a liberal conceptualization of insomnia and only assessed for nocturnal sleep 
disturbances (Heath, Kendler, Eaves, & Martin, 1990; McCarren, Goldberg, 
Ramakrishnan, & Fabsitz, 1994; Partinen, Kaprio, Koskenvuo, Putkonen, & 
Langinvainio, 1983; Watson, Goldberg, Arguelles, & Buchwald, 2006). Furthermore, 
such studies present varying heritability rates for insomnia and related symptoms from 
28% to over 60%. This study is intended to extend the scientific literature by using a 
more comprehensive assessment of sleep problems including nocturnal sleep 
disturbances, associated daytime impairment, and sleep dissatisfaction. In addition to 
providing heritability estimates for specific symptoms of insomnia, this study provides a 
heritability estimate for a global measure of sleep problems that closely reflects a 
diagnosis of insomnia, which has not been done in previous work. 
Hypothesis. Previous studies demonstrate significant genetic influences and no 
shared environmental influences on insomnia-related sleep problems. I predicted that 
consistent with previous findings, there would be a significant additive genetic influence 
and no common environmental influences on insomnia symptoms. A priori predictions 
of a heritability estimate of insomnia were not made given the variability of results from 
previous studies. 
Specific Aim 2: Common genetic influences on symptoms of insomnia and 
depression (Chapter 3) 
Rationale. Previous research demonstrated that insomnia is highly comorbid 
with depression. No behavioral genetic study to date, however, has explored the nature 
of this relationship. Two twin studies have examined related constructs (i.e., poor sleep 
and life dissatisfaction; chronic fatigue and depression) and report independent genetic 
liabilities (Paunio et al., 2009; Roy-Byrne et al. , 2002). The aim of this study was to 
evaluate the extent to which genetic and environmental influences contribute to the 
comoribidy of insomnia and depression, specifically assessing the extent to which these 
two disorders share a single genetic liability or independent liabilities. 
Hypothesis. I predicted that the shared genetic relationship between insomnia 
and depression would not be entirely specific or nonspecific. While there may be some 
genetic overlap contributing to co-occurrence, the majority of the genetic liability would 
be influenced by unique additive genetic effects. This hypothesis is based on the two 
bivariate twin studies described above that reported separate genetic influences on 
constructs related to insomnia and depression. Since these studies did not specifically 
examine insomnia and depression, the possibility that a common genetic liability 
underlies insomnia and depression could not be ruled out. 
Specific Aim 3: Insomnia, depression, and cognitive impairments (Chapter 4). 
Rationale. Individuals with insomnia and related sleep complaints exhibit 
impairments in numerous cognitive domains (Bastien et al., 2003; Nebes et al. , 2009; 
Szelenberger & Niemcewicz, 2000). Results from these studies, however, are largely 
5 
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conflicting, and there is little evidence of a single and consistently reported cognitive 
deficit in insomnia patients (Fulda & Schulz, 2001; Shekleton, Rogers, & Rajaratnam, 
2010). Given the inconsistent results, this study aimed to clarify the impact of insomnia 
on cognitive functioning. As described above, insomnia and depression are highly 
comorbid. Since both disorders are associated with impairments in cognitive functioning, 
this study also attempted to explain the interrelationships between insomnia, depression, 
and cognitive performance. Specifically, this study examined the effects of insomnia on 
cognitive performance after adjusting for depression (and other covariates), and vice 
versa. 
Hypothesis. I predicted that insomnia symptoms will be associated with 
cognitive deficits in numerous domains. An a priori prediction of the relation between 
insomnia and impairments in other specific cognitive domains was not made due 
inconsistencies in the literature. I suspected, however, that insomnia would be most 
strongly associated with impairments in working memory given that more often than not, 
studies have demonstrated a relation between insomnia and working memory (Shekleton 
et al., 2010). In terms of the relation between insomnia, depression, and cognition, I 
predicted that while depression may mediate the relation between insomnia and certain 
cognitive domains, there would be an association between insomnia and cognitive 
deficits in some domains independent of depression. 
Specific Aim 4: Mechanisms by which insomnia impacts cognition: Insomnia X 
gene interaction and the role of cortisol and hippocampal volume (Chapter 5). 
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Rationale. The aim of this study was to elucidate the process of insomnia-related 
cognitive decline. The first specific aim was to explore the interaction between insomnia 
and the apolipoprotein E (apoE) gene, a susceptibility gene for Alzheimer's disease (AD). 
ApoE has also been linked to cognitive performance in non-demented adults, in part 
through its impact on the ability to compensate for neuronal insult, and seems to have a 
greater effect on cognitive functioning over time. The study aimed to examine whether 
sleep problems differentially impair cognition in individuals based on apoE status. 
This study also· attempted to explore the mechanisms by which sleep impacts 
neuronal integrity, specifically through its relation with cortisol and hippocampal volume. 
Numerous studies have reported a strong relation between insomnia and increased 
cortisol (Rodenbeck, Huether, Ruther, & Hajak, 2002; Vgontzas, Bixler, Lin, et al., 
2001), although some studies report no association (Riemann et al., 2002), and between 
cortisol and hippocampal volume (Lupien et al., 2005). Several recent studies examined 
the relation between insomnia and hippocampal volume, although the results of those 
studies are inconsistent (Altena, Vrenken, VanDerWerf, van den Heuvel, & Van 
Someren, 2010; Riemann et al., 2007; Winkelman et al., 2010). Another goal of this 
dissertation was to contribute to the literature on insomnia and hippocampal volume and 
to examine whether cortisol mediates the relation between insomnia and hippocampal 
volume, which has not been examined to date. 
Hypothesis. I predicted that the effects of apoE on cognitive functioning may not 
be detectable across the majority of cognitive domains. Prior research had found that age 
related cognitive decline typically begins in the mid 60's (Finkel, Reynolds, McArdle, 
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Gatz, & Pedersen, 2003; Giambra, Arenberg, Kawas, Zonderman, & Costa, 1995), with 
some indication of decline in the 50's (MacDonald, Hultsch, & Dixon, 2003), so 
participants (who were, on average, 55.6 years old) may be just beginning to experience 
signs of cognitive decline. I also predicted that there would be an interaction effect 
between insomnia and apoE, in that among individuals with insomnia, e4 carriers will 
demonstrate significantly greater cognitive impairment compared to non-carriers, but that 
among individuals without insomnia, cognitive functioning would not differ based on e4 
status. Based on the literature, I predicted that there would be a significant relation 
between insomnia and cortisol and between insomnia and hippocampal volume. I 
suspected that given the robust relation between insomnia and cortisol reported in the 
much of the literature and the role of cortisol on neuronal degradation, cortisol would 
mediate the relation between insomnia and hippocampal volume. 
Significance 
Insomnia is a highly prevalent disorder and is associated with numerous negative 
outcomes, including cognitive impairments and co-occurring psychiatric disorders such 
as depression. Studying insomnia in aging populations is critical since the prevalence of 
insomnia increases with age and cognitive preservation is of central importance in aging. 
The present series of studies extend the scientific literature on the etiology of insomnia, 
the relationship between insomnia and depression, and the mechanisms through which 
insomnia impacts cognitive decline (i.e. , the role of depression, cortisol, hippocampal 
volume, and apoE). Findings from these studies have significant public health 
implications and may direct future research on prevention and intervention techniques. 
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For example, understanding the extent to which symptoms of insomnia and depression 
share a single genetic liability may inform the conceptualization and treatment of co-
occurring insomnia and depression. Examining the effect of insomnia on impairments in 
specific cognitive domains and the mechanisms by which insomnia impacts cognition 
may provide insight into the best approaches for preventing and treating cognitive 
decline. The apoE gene has been identified as an important factor in mental health and 
cognitive outcomes, and this study contributes to the literature regarding the specific 
effects of apoE on cognition and the nuanced ways in which sleep may affect cognitive 
functioning. Furthermore, because this study utilized the first wave of data from a 
longitudinal study of aging, it will set the stage for future analyses focusing on insomnia 
and cognitive functioning over time. 
General Methods 
Detailed methods for Specific Aims 1, 2, 3, and 4 are provided in chapters two, 
three, four, and five, respectively. General methods that pertain to all studies are 
reviewed in the following section. 
Participants 
The participants were drawn from the Vietnam Era Twin Study of Aging 
(VETSA), a longitudinal study of cognitive and brain aging. The VETSA project and 
assessment protocols have been described in detail elsewhere (Kremen et al., 2006). 
Baseline data for this study of risk and preventive factors in cognitive aging were 
collected in assessments conducted from 2003-2007. Participants live throughout the 
United States and were given the option of traveling to San Diego or Boston for a day-
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long series of assessments. The studies in this dissertation examined 123 7 twin subjects 
(age range: 51-60) collected during the first wave ofVETSA. A combination of DNA 
testing, questionnaire, and blood group methods were used to determine zygosity (Eisen, 
True, Goldberg, Henderson, & Robinette, 1987); comparisons of the genotype-based and 
questionnaire-based zygosity measures indicated 96% accuracy. 
All participants in VETSA were randomly selected from the Harvard Drug Study 
(HDS), which consisted of3,322 twin pairs (6,644 individuals). The HDS was conducted 
from 1991-1993 when twins were, on average, 44.6 years old (sd 2.8; range, 36-55). 
Lifetime diagnoses and symptoms of mental disorders were assessed through telephone 
interviews. A review of the HDS is described in a previous manuscript (Tsuang, Bar, 
Harley, & Lyons, 2001). 
All participants in the Harvard Drug Study were recruited from the Vietnam Era 
Twin (VET) Registry, a non-clinical, population based cohort of male-male twin pairs. 
Ascertainment procedures for the registry have been described previously (Eisen et al., 
1987; Henderson et al., 1990). In brief, the VET Registry consists of7,375 male-male 
monozygotic and dizygotic twins born between 1939 and 1957 who were raised together 
and served on active duty in the United States military at some point during the Vietnam 
Era (1965-1975). The majority of participants (68%) did not serve in combat or in 
Vietnam, and of the participants who served in Vietnam, 113 of this group reported some 
combat experiences, and none have been in the military service during the past 20 years 
(Eisen et al., 1987; Henderson et al., 1990). Women were not in the Registry due to the 
relatively small number of women in the military during that era. 
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The VETSA sample is representative of basic demographic and health 
characteristics of American men in this age range based on US census data (Kremen et 
al., 2006). VETSA participants' mean age was 55.6 years, and mean education was 13.8 
years. At the time of data collection, 17.9% of subjects were retired. 89.7% of the 
subjects were Caucasian, 4.1% were African American, and 2.7% were Hispanic. The 
majority (78.3%) of subjects were married, with 10.9% divorced, 1.9% separated, 8.3% 
single, and 0.7% widowed. Self-reported overall health status was as follows: excellent 
(12%), very good (36.5%), good (39.1 %), fair (10.4%), and poor (1.3%). In terms of 
mental health status, 9. 4% of subjects reported currently having depression and 3. 7% of 
subjects reported currently having an anxiety disorder (assessed by asking "Has a doctor 
told you that you have depression or an anxiety disorder"). 
The Pittsburgh Sleep Quality Index (PSQI) 
The PSQI is a widely-used and well-validated scale that assesses symptoms of 
insomnia over the preceding month. This assessment consists of 19 questions, which are 
scaled into seven component scores and totaled to provide a global score ranging from 0-
21, with higher scores representing more sleep problems. A global PSQI score of six or 
above has been found to have a diagnostic sensitivity of 89.6 and specificity of 86.6 in 
distinguishing individuals with clinically significant sleep problems from those without 
clinically significant sleep problems, and studies have shown that this cutoff yields 
groups significantly different in polysomnographic evidence of sleep disruption (Buysse, 
Reynolds, Monk, Berman, & Kupfer, 1989). A more recent study found that this cutoff 
discriminates individuals with primary insomnia from controls with a sensitivity of 
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98.7% and a specificity of 84.4% (Backhaus, Junghanns, Broocks, Riemann, & Hohagen, 
2002). Of note, scores on the PSQI do not provide a DSM diagnosis of insomnia; 
nevertheless, cutoff scores on the PSQI will be referred to as "insomnia" throughout this 
dissertation since the PSQI closely reflects having a diagnosis of insomnia. This 
assessment measure is a widely used questionnaire with established reliability and 
validity (Buysse et al., 1989). 
The seven component scores of the PSQI include subjective sleep quality ("how 
would you rate your sleep quality overall"), sleep latency ("how long has it usually taken 
for you to fall asleep each night"), sleep duration ("when have you usually gone to bed at 
night," "when have you usually gotten up in the morning"), habitual sleep efficiency 
("how many hours of actual sleep did you get at night, which may be different than the 
number of hours you spent in bed"), sleep disturbances ("how often have you had trouble 
sleeping because you cannot get to sleep within 30 minutes, wake up in the middle of the 
night or early morning, have to get up to use the bathroom, cannot breathe comfortably, 
cough or snore loudly, feel too cold, feel too hot, had bad dreams, or had pain"), use of 
sleep medications ("how often have you taken medication, prescribed or over-the-
counter, to help you sleep"), and daytime dysfunction ("how often have you had trouble 
staying awake while driving, eating meals, or engaging in social activities," "how much 
of a problem has it been for you to keep up enough enthusiasm to get things done"). 
There are four response options that reflect the frequency of problems sleeping during the 
past month, including "not during the past month," "less than once a week," "once or 
twice a week," and "three or more times a week." For the questions that do not use these 
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response options, such as the number of hours slept and usual bedtime, responses are 
grouped into four categories. The derivation of the component scores in the present study 
was based on scoring instructions outlined by Buysse and colleagues (Buysse et al., 
1989). The composite PSQlscore was created by adding each component score. 
Specific Aims .1 and 2 used the composite PSQI score in the analysis, and Specific Aims 
3 and 4 used the composite score in addition to a dichotomized variable derived from the 
cut-off score (score of 6 or above). Global PSQI scores were positively skewed 
(skewness 1.12; standard error .07; Kolmogorov-Smimov Z = 5.703, p<.OOO), and a 
square root transformation was applied to the data to achieve a normal distribution. 
Applying a square root transformation resulted in a mean score of2.2 (s.d . . 75) (skewness 
.27; standard error .07; kurtosis .29; standard error .14). 
CHAPTER TWO: 
The genetic and environmental influences on symptoms of insomnia 
Introduction 
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Twin studies have examined the extent to which genes and the environment 
contribute to the variability of symptoms of insomnia. The twin method compares 
resemblance between identical (monozygotic; MZ) twins to resemblance between 
fraternal (dizygotic; DZ) twins. Although twins grow up in the same household, they 
differ in genetic relatedness depending on zygosity, making them an ideal natural 
experiment. Because MZ twins share approximately 100% of their genes compared to 
DZ twins who share approximately 50% of their segregating genes, MZ twins should be 
more similar to each other on traits that are genetically influenced. Environmental 
experiences can contribute to both similarities and differences between twins in the same 
family, and twin methods can determine the extent to which genes or the environment 
contributes to similarities (i.e., shared/common environment) and differences (i.e., non-
shared/unique environment) between twin pairs. 
Twin studies have reported that insomnia is heritable (i.e., influenced by genetic 
factors) (Heath et al., 1990; McCarren et al., 1994; Partinen et al., 1983; Watson et al., 
2006). However, most of these studies use a liberal conceptualization of insomnia and 
only assessed for nocturnal sleep disturbances. For example, in a study of twins from the 
University of Washington twin registry, Watson and colleagues (2006) found 57% of the 
variation in individual differences in symptoms of insomnia to be explained by additive 
genes, and the remainder of the variance was attributed to unique environmental 
influences. The mean age oftwins was 32 years. Insomnia in Watson et al.'s (2006) 
study was assessed using only one question: "How often do you have trouble falling 
asleep or staying asleep?" 
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In a twin study from the Vietnam Era Twin (VET) Registry, McCarren and 
colleagues (1994) also reported a significant heritability for insomnia with negligible 
common environmental influence on the variation of insomnia. Subjects' age ranged 
from 33 to 51 years. Four questions were used to assess sleep problems: "how often in 
the past month did you have trouble falling asleep, wake up several times per night, have 
trouble staying asleep, and wake up after your usual amount of sleep feeling tired or worn 
out?", and a composite sleep score was derived. The composite sleep measure had a 
heritability of28%, with the remaining variance due to non-shared environment. The 
present study and McCarren et al. 's (1994) study utilized subjects from the VET 
Registry. McCarren and colleagues' (1994) research was part of the Survey of Health 
and the National Heart Lung and Blood Institute Survey (NHLBI) studies, and I utilized 
data from the Vietnam Era Twin Study of Aging (VETSA). While these are different 
subsets of VET Registry members, there is substantial subject overlap. 
In addition to studying the heritability of nocturnal sleep disturbances, Partinen 
and colleagues (1983) also examined the heritability of subjective sleep quality in 
subjects (age 18 and older) from the Finnish Twin Registry. Sleep length was assessed 
by the number of hours slept, and sleep quality was assessed by rating sleep as "good, 
fairly good, fairly poor, or poor." Additive genetic effects accounted for 44% of the 
variance in both sleep length and overall sleep quality: 
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Finally, in a study from the Australian Twin Registry, Heath and colleagues 
( 1990) utilized a more thorough assessment of sleep problems that included sleep pattern 
(daytime napping, habitual bedtime, sleep time, and sleep duration), quality (overall 
quality, depth of sleep, and variability of quality), and disturbance (initial insomnia, 
disturbed sleep, anxious insomnia, depressed insomnia, sleep delay). Additive genetic 
influences of symptoms of insomnia ranged from 20-61%, and non-additive genetic 
effects were reported for three symptoms of insomnia, sleep depth, disturbed sleep, and 
sleep duration. Subjects' age ranged from 17 to 88. The authors did not report 
heritabilities for a composite measure of insomnia based on all symptoms. Although the 
Australia study used the most comprehensive measure of sleep problems to date that 
included 12 sleep-related questions, the authors did not assess for associated daytime 
impairment, which is a diagnostic criterion of insomnia in the DSM. 
The studies described above present varying heritability rates for insomnia and 
related symptoms from 20% to over 60%. The majority of fmdings from these studies 
demonstrate that the common environment does not explain the variation of insomnia in 
population samples. Moreover, with the exception of Heath and colleagues' ( 1990) 
study, previous research used a liberal conceptualization of insomnia having only 
assessed for nocturnal sleep disturbances. One other study (Partinen et al., 1983) 
addressed subjective sleep quality in addition to nocturnal sleep disturbances through a 
single question on sleep dissatisfaction. The present study aimed to build upon previous 
literature through the use of a more comprehensive assessment measure of symptoms of 
insomnia and through examination of nocturnal sleep disturbances and sleep quality as 
17 
well as associated daytime impairments. This study also aimed to achieve a heritability 
estimate for a global composite measure based on multiple symptoms of insomnia and 





Of the 123 7 twins in the VETS A study (described in Chapter 1 ), 1212 had 
complete Pittsburgh Sleep Quality Index (PSQI) data (668 MZ and 544 DZ twins) and 
were included in this study. 
Assessments 
The Pittsburgh Sleep Quality Index was used to assess symptoms of insomnia. 
The global PSQI score (continuous variable) and the seven component scores of the PSQI 
were examined. 
Data Analysis 
The total PSQI composite score was treated as a continuous variable in the 
genetic analysis. Since scores on the PSQI were positively skewed (skewness 1.12; 
standard error .07; Kolmogorov-Smimov Z = 5.703, p<.001), a square root 
transformation was applied to the data to achieve a normal distribution. Applying a 
square root transformation resulted in a mean score of2.2 (s.d . . 75) (skewness .27; 
standard error .07; kurtosis .29; standard error .14). The distributions of the raw scores 
are provided in Figure 2.1. In addition, I examined the genetic and environmental 
influences on each component score of the PSQI. Each component score was treated as 
an ordinal variable, with values ranging from 0 to 3, and a threshold-based model was 
used to calculate the proportion of the sample that fell into each category. 
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Genetic analyses were performed utilizing the structural equation modeling 
software package Mx (Neale, Boker, Xie, & Maes, 2003). In the classic twin design, the 
variance of any trait or phenotype can be partitioned into the proportion that is due to 
additive genetic effects (A), shared or common environmental influences (C), and non-
shared or individual-specific environmental influences (E). Shared/common 
environmental influences refer to environmental factors that contribute to twin l')imilarity, 
while non-shared environmental influences refer to environmental factors that contribute 
to differences between twins. Measurement error is included in non-shared 
environmental variance, as it is assumed to be random-- that is, uncorrelated across twins. 
All models were fit to the raw data by means of maximum likelihood. Analysis of 
individual components assumed a variance of 1.0 for each ordinal component. For all 
analyses, I first fit a saturated model that captures the observed data perfectly and then 
tested whether more parsimonious models could account for the data without a significant 
reduction in fit. The full model (ACE) and reduced models that delete either A or C 
effects were compared to the saturated model. 
A chi-square difference test was used to assess whether a reduced model fits the 
data significantly more poorly than the full model by comparing the difference in -2 log 
likelihood (-2LL) for each sub-model (through the likelihood-ratio statistic). The Akaike 
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Information Criterion (AI C) (Akaike, 1987) was also used to identify the goodness of fit 
and parsimony; the more negative the AIC, the better the balance between the two. 
Results 
Participants' sleep characteristics are presented in Table 2.1. The mean PSQI 
score was 5.6 (standard deviation 3.6) and the median was 5.0, with scores ranging from 
0-20. Forty percent of subjects can be classified as having clinically significant poor 
sleep, as reflected by a PSQI score of six or above, and 60% of subjects had a score 
below 6. There were no significant differences in PSQI score between MZ and DZ twins. 
Heritability of the Composite Score for Insomnia 
The MZ twin correlation for the composite PSQI score was .33 (p < .001), and the 
DZ twin correlation was .19 (p < .01 ). Model fit estimates for the full model and nested 
models are provided in Table 2.2, and variance component estimates and parameter 
estimates for the full and best model are depicted in Figure 2.2. Results of the full model 
showed that 28% (95% confidence interval 0-42) of the variability of symptoms of 
insomnia was due to additive genetic effects, 5% (95% confidence interval 0-29) of the 
variance was due to common/shared environmental effects, and 67% (95% confidence 
. interval 60-77) of the variability was due to unique environmental influences. While 
neither the AE nor CE models fit the data significantly more poorly than the full ACE 
model, dropping the common environmental effects from the model (AE model) provided 
the best fit to the data based on AIC values. In the AE model, 34% (95% confidence 
interva125-42) of the variance was due to additive genetic effects and 66% (95% 
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confidence interval58-75) of the variance was due to unique environmental effects. The 
full ACE and the AE models are depicted in Figure 2.2. 
Heritability of Individual Component Scores 
The MZ and DZ correlations, respectively, for each component score of the PSQI 
were as follows: sleep quality (.30, .21), sleep efficiency (.21, .15), sleep duration (.28, 
.15), sleep latency (.3\ .19), sleep disturbances (.19, .18), sleep medication (.31, .32), 
and daytime disturbances (.28, .15). Parameter estimates for the full and best-fitting 
models of each component score are provided in Table 2.3. Based on the Akaike 
Information Criterion, the AE model provided the best fit for five out of the seven 
component scores of the PSQI: sleep quality, sleep efficiency, sleep duration, sleep 
latency, and daytime disturbances. Heritabilities for these components ranged from .15 
to .28 in the full ACE models, and .23 to .34 for the best models. The CE model provided 
the best fit for two of the component scores of the PSQI: sleep disturbances and use of 
sleep medication. In the best model, shared environmental factors accounted for 18% of 
variation in sleep disturbances and 31% of variance in use of sleep medication, with the 
remainder due to nonshared environmental factors. 
Discussion 
The present study used a classic twin design to determine the extent to which 
individual differences in insomnia were due to genetic and environmental influences. 
Results ofthe full model showed that 28% of the variability in insomnia was explained 
by additive genetic influences, 5% was explained by common/shared environmental 
influences, and 67% was explained by non-shared environmental influences. Dropping 
common/shared environmental influences improved the model fit based on the AIC 
values, resulting in a heritability estimate of 34%. 
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The heritability estimate of the PSQI derived in the current study is consistent 
with estimates from several previous studies that have examined nocturnal sleep 
disturbances (28% in McCarren et al. and 44% in Partinen et al.) and subjective sleep 
quality (44% in Partinen et al.). My results are closest to some of the symptoms of 
insomnia assessed bYHeath and colleagues (1990), who used a questionnaire that was 
validated against laboratory-based EEG measures of sleep, and has good consistency over 
time (Heath et al., 1990; Lewis & Lewis, 1976). The majority of insomnia symptoms in 
Heath et al. 's study had heritability rates of 32-39%, including overall sleep quality, 
initial insomnia, sleep delay in women, depressed insomnia, anxious insomnia, sleep time 
in men, and daytime napping. Some of the symptoms of insomnia assessed by Health et 
al. are quite different from my estimate of insomnia (34%), such as sleep variability 
(20%) and sleep depth (61 %). 
Watson and colleagues (2006) found the additive genetic effects on nocturnal 
sleep disturbances to be greater (57%) than what was reported in the present study (34%). 
The authors suggested that this high heritability estimate may reflect the younger age of 
twins in their sample (mean age= 32 years). They conjectured that more subjects may 
have had child-onset insomnia, which may be more genetically driven than the adult-
ons~t type. This hypothesis is consistent with previous findings, in which individuals 
with child-onset insomnia or insomnia beginning in adolescence or early adulthood had 
more family members With sleep difficulties compared to individuals with adult-onset 
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insomnia (Bastien, Leblond, Pichette, & Villeneuve, 2000; Hauri & Olmstead, 1980). 
However, Heath and colleagues (1990) examined the change in genetic influences of 
insomnia over time (twins age 17-88) and found no evidence for a decline in the 
importance of genetic influence with age. Heath et al. ( 1990) noted that failure to find 
evidence for age-related differences in heritability may reflect a problem of statistical 
power. Because the present study utilized baseline data from a longitudinal twin study of 
aging with a plan to follow-up twins every five years, I will be able to examine change in 
genetic and environmental influences over time. 
As described above, previous studies examining the heritability of insomnia 
symptoms reported inconsistent findings, with heritability estimates ranging from 20% to 
over 60%. Most of these studies only reported on the heritability of a limited number of 
symptoms of insomnia, and results ofthe present study are unique in that an estimate of 
genetic and environmental influences on a composite measure that has been shown to 
closely reflect diagnostic criteria is provided (Buysse et al., 1989). As a follow-up 
analysis, I examined each component score of the PSQI to determine whether heritability 
estimates varied across different types of symptoms of insomnia, which could account for 
inconsistencies across previous studies. The AE model was the best fit for five of the 
component scores, and the additive genetic influences ofthese scores (sleep quality, 
efficiency, duration, latency, and daytime disturbances) were very stable, ranging from 
28% to 34%. These estimates were similar to the overall heritability estimate of the PSQI 
(34%). 
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I acknowledge that dropping the common/shared environmental pathway from the 
models may result in overestimating the additive genetic effects, as the variance 
explained by C in the full model is often represented in A of the nested model. 
Nevertheless, the parameter estimates obtained in the AE models are an appropriate 
interpretation of heritability for two reasons. First, the AE models provided a better fit in 
comparison to the CE models for the composite PSQI measure and for five out of the 
seven component scores. Second, estimates of additive genetic influences obtained in the 
full ACE models were not significant for either the composite score or the individual 
component score analyses. 
The CE model provided the best fit for two component scores: sleep disturbances 
and use of sleep medication. By contrast, Heath and colleagues (1990) found that 
additive genes did not influence sleep disturbances, and instead, dominant genetic effects 
(D) were reported. Additive genetic effects occur when the genetic variation in a trait is 
determined by a large number of genes acting independently, all of which have a small 
effect. Dominant genetic effects result from either a single gene of major effect or an 
interaction between alleles at different loci. While results in the present study differ from 
Heath and colleagues in that MZ and DZ correlations for sleep disturbances were almost 
identical (.19 and .18, respectively), it is possible that the presence of C may offset the D 
effects. The effects of the common environment and genetic dominance cannot be 
estimated simultaneously because they have identical effects that are opposite in direction 
(i.e., whileD reduces the DZ twin correlation to below one half the MZ correlation, C 
inflates the DZ twin correlation to greater than one half the MZ correlation). A future 
examination of dominant genetic influences on sleep disturbances is needed. 
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More research is needed to replicate findings related to the use sleep medications, 
as to my knowledge, no twin study has examined the genetic and environmental 
influences on medication use. Unpublished data from the VETSA sample suggests a 
shared environment effect on self-reports of taking other types of medication. For 
example, the DZ correlation for taking any medications was .12, compared to an MZ 
correlation of .06, indicating that the family resemblance for medication use is due to 
environmental, not genetic factors. It is possible that factors related to the family 
environment, such as education level and family income, predict medication use. 
Parents' tendency to give their children medications for pain, colds, or other illnesses 
may also influence subjects' propensity to take medication for sleep problems in middle 
age. A best-fitting CE model for the use of sleep medication in the current study, 
therefore, may reflect learned behavior or resources based on the influence of the twins' 
family environment. 
Understanding the etiology of insomnia has significant public health implications. 
Examining the extent to which genes and the environment impact the development of 
insomnia may help to inform treatment approaches. The next step may be to identify 
specific environmental factors and specific genes that influence insomnia in order to 
focus prevention and intervention strategies. No studies to date have identified specific 
genes related to insomnia, although one gene has been identified that is related to sleep 
patterns. A genetic variant of adenosine dearninase was found to be associated with 
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enhanced slow wave activity during sleep, and a polymorphism of the adenosine A2 
receptor gene was found to be associated with less slow wave sleep (Retey et al., 2005). 
Future work to determine the genetic basis of insomnia should involve genome-wide 
scans of insomniacs and healthy sleepers to identify candidate genes. It is also possible 
that the impact of the environment on sleep may vary based on the presence of specific 
genes, resulting in a gene by environment interaction. If this were the case, genes may 
play a larger role than what is suggested in the present study, and possible gene by 
environment interaction effects should be examined. 
Treating insomnia is particularly relevant in the aging population, as the 
prevalence of insomnia increases with age (Morphy et al., 2007; Rosekind, 1992; Roth & 
Roehrs, 2003). Insomnia is also related to problems that become more common with 
increasing age, such as deficits in memory consolidation and other cognitive processes 
(Bastien et al., 2003; Buysse et al., 2008; Nebes et al., 2009; Szelenberger & 
Niemcewicz, 2000), and therefore understanding the etiology of insomnia is particularly 
relevant to elderly populations. The longitudinal nature of this study will enable me to 
explore changes in sleep patterns and to elucidate specific factors that impact symptoms 
of insomnia over time. Of note, the average number of hours of sleep in the current 
sample (6.4 hours) is below what the National Sleep Foundation recommends for good 
health in adults (7 -9 hours). Less than optimal hours of sleep may reflect the age range of 
this sample, as a meta-analysis of 65 studies found that total hours of sleep decreased 
from age 19 to older adulthood (Ohayon, Carskadon, Guilleminault, & Vitiello, 2004). 
The meta-analysis also found that total hours of sleep remained stable from age 60 to age 
26 
102. Given that participants in the current study were, on average, in their mid 50's, I do 
not expect the total number of hours of sleep to significantly decrease over time. On 
average, the sleep efficiency of this sample was good (88%), as normal sleep efficiency is 
reported to be at least 80-85% (Morin, 1993). I expect that sleep efficiency in this sample 
will decrease overtime, as sleep efficiency has been found to decline across the full adult 
lifespan (age 19-102) (Ohayon et al., 2004). 
This study has several limitations. First, I used a subjective sleep measure as 
opposed to electroencephalogram (EEG) or actigraphy to assess sleep problems. EEG or 
actigraphy would be difficult to implement with the large sample in the current study and 
the limitations on their available time for testing. An advantage of the PSQI, a subjective 
self-report questionnaire, is that it is a reliable and valid measure with high diagnostic 
sensitivity and specificity in distinguishing good and poor sleepers (Buysse et al., 1989). 
A second limitation was that this sample was restricted to male twins from ages 51-60. 
Results may not generalize to women or to other age groups. Sleep problems in women 
of this age group may be, in part, etiological different from sleep problems in men given 
the associated sleep problems as a result of hormonal changes that occur in women of this 
age. A final limitation to this study was that the PSQI is a onetime assessment of 
insomnia, measuring sleep problems over the previous month. This instrument reflects 
current sleep problems and fails to capture symptoms throughout one's lifetime, which 
may explain why a large amount of the variance is explained by unique environmental 
influences. Previous research, however, has demonstrated that over the course of a year, 
scores on the PSQI remain stable (Knutson, Rathouz, Yan, Liu, & Lauderdale, 2006). 
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This is the first study to examine the genetic and environmental influences on 
insomnia using a measure that closely reflects diagnostic criteria. Previous studies have 
either used limited assessments of insomnia or have only reported heritability estimates 
for specific symptoms. In addition to examining the heritability of individual symptoms 
of insomnia, this study attained a more meaningful heritability estimate reflecting a 
composite measure of nocturnal sleep disturbances, sleep quality, and daytime 
dysfunction. As a baseline to a longitudinal study, it sets the stage for future research on 
the genetic and environmental influences of insomnia over time. 
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Table 2.1. 
Sleep Characteristics from the Pittsburgh Sleep Quality Index. 
Mean Standard 
(minutes) Deviation 
Time to fall asleep 19.2 24.5 
Normal hours of sleep 6.4 1.3 
Sleep efficiency 88.4% 16.7% 
Very good Fairly good Fairly bad Very bad 
Overall sleep quality 345 (27.9%) 718 (58.0%) 138 (11.2%) 36 (2.9%) 
Not during Less than Once or Three or 
the past once a twice a more times 
week week week per week 
Cannot fall asieep within 30 minutes 562 (45.4%) 388 (31.4%) 147 (11.9%) 139 (11.2%) 
Wake up during the night 340 (27.5%) 300 (24.3%) 241 (19.5%) 356 (28.8%) 
Have to use the bathroom 359 (29.0%) 284 (23.0%) 227 (18.4%) 366 (29.6%) 
Cannot breath comfortably 1087(87.9%) 71 (5.7%) 33 (2.7%) 41 (3.3%) 
Cough or snore loudly 1013(81.9%) 103 (8.3%) 51 (4.1%) 70 (5.7%) 
Feel too cold 1 063(85 .9%) 117 (9.5%) 38 (3.1%) 18 (1.5%) 
Feel too hot 888 (71.8%) 206 (16.7%) 102 (8.2%) 41 (3.3%) 
Had bad dreams 1037(83.8%) 130 (10.5'%) 38 (3.1 %) 30 (2.4%) 
Had pain 892 (72.1%) 153 (12.4%) 91 (7.4%) 100 (8.1%) 
Took medicine to help sleep 1025(82.9%) 81 (6.5%) 36 (2.9%) 95 (7.7%) 
Had trouble staying awake during day 1 059(85.6%) 111 (9.0%) 44 (3 .6%) 23 (1.9%) 
Lack of enthusiasm for getting things done 683 (55.2%) 389 (31.4%) 135 (10.9%) 29 (2.3%) 
Note. Sleep efficiency= (total number of hours asleep I total number of hours in bed) X 100. 
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Table 2.2. 
Model fit estimates for genetic and environmental influences on insomnia (PSQJ score). 
Results from the saturated model that capture the observed data perfectly and more 
parsimonious models are displayed. The lower AIC value reflects the best model that can 
account for the data without a significant reduction in fit. 
-2LL df A df A Chi-sq p value AIC 
Saturated Model 2684.31 1202 267.21 
ACE 2685.21 1209 7 0.89 0.99 -13.1 
AE 2685.35 1210 8 1.04 0.99 -14.96 
CE 2688.9 1210 8 4.59 0.8 -11.41 
E 2733.64 1211 9 49.33 <.001 31.33 
Note. A= additive genetic influences, C= common/shared environmental influences, E= 
non-shared environmental influences, -2LL= -2 log likelihood, df= degrees of freedom, 
AIC= Akaike's Information Criterion. 
30 
Table 2.3. 
Variance component estimates for the full (ACE) and best-fittingmodels of the seven 
individual component scores of insomnia. 
Heritability Common/Shared Non-shared 
Environment Environment 
a 2 (95% Cl) c2 (95% CI) e2 (95% CI) 
Sleep Quality ACE .19 (.00, .41) .11 (.00, .34) .70 (.59, .81) 
AE .31 (.20, .42) .69 (.58, .80) 
Sleep Efficiency ACE .15 (.00, .37) .07 (.00, .30) .78 (.63 , .94) 
AE .23 (.08, .37) .77 (.62, .92) 
Sleep Duration ACE .27 (.00, .39) .01 (.00, .28) .72 (.61, .83) 
AE .28 (.18, .39) .71 (.61, .82) 
Sleep Disturbances ACE .02 (.00, .34) .17 (.00, .29) .81 (.66, .93) 
CE .18 (.07, .29) .82 (.71, .93) 
Sleep Latency ACE .28 (.00, .44) .05 (.00, .32) .67 (.56, .79) 
AE .34 (.23, .44) .66 (.56, .77) 
Sleep Medication ACE .03 (.00, .49) .29 (.00, .45) .68 (.50, .84) 
CE .31 (.16, .45) .69 (.55, .84) 
Daytime Dysfunction ACE .22 (.00, .41) .06 (.00, .30) .72 (.59, .85) 
AE .29 (.16, .41) .71 (.59, .84) 
Note. A= additive genetic influences, C= common/shared environmental influences, E= 
non-shared environmental influences, a2= the amount of variability of insomnia 
explained by additive genetic influences, c2= the amount of variability of insomnia 
explained by common environmental influences, e2= the amount of variability of 
insomnia explained by non-shared environmental influences, CI =confidence interval. 
Figure 2.1. 
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Note. The mean PSQI score was 5.6 (standard deviation 3.6) and the median was 5.0, 
with scores ranging from 0-20. Since scores on the PSQI were positively skewed 
(skewness 1.12; standard error .07; Kolmogorov-Smimov Z = 5.703, p<.OOO), a square 
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root transformation was applied to the data to achieve a normal distribution. Applying a 
square root transformation resulted in a mean score of2.2 (s.d .. 75) (skewness .27; 
standard error .07; kurtosis .29; standard error .14). 
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Figure 2.2. 
Heritability estimates, confidence intervals, and path coefficients for the full (ACE) and 





Note. A= additive genetic influences, C= common environmental influences, E= unique 
environmental influences. Values adjacent to the lines are standardized variance 
components, and values in parenthesis are 95% confidence intervals for the standardized 
variance components. a2= proportion of variance due to genetic influences, c2= 
proportion of variance due to common/shared environmental influences, e2= proportion 
of variance due to non-shared environment. Values in brackets are path coefficients. 
CHAPTER3: 
The common genetic influences on symptoms of insomnia and depression 
Introduction 
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The vast majority of insomnia cases have co-occurring psychiatric disorders 
(Ohayon, 1996), and the literature consistently reports strong evidence for the 
comorbidity of insomnia and depression. Studies have found that 35-47% of people with 
insomnia also have depression (Buysse et al. , 1994; McCall, Reboussin, & Cohen, 2000), 
and people with insomnia are 9.8 times more likely to have depression compared to 
people without insomnia (Taylor, Lichstein, Durrence, Reidel, & Bush, 2005). 
Furthermore, 60-90% of patients with depression also report significant symptoms of 
insomnia (Ford & Kamerow, 1989; Hatoum, Kong, Kania, Wong, & Mendelson, 1998; · 
Tsuno, Besset, & Ritchie, 2005). The nature of the relationship between depression and 
insomnia is unclear, which often leads to confusion when diagnosing primary and 
secondary subtypes of insomnia. One diagnostic criterion in the DSM for depression 
includes sleep problems. The high comorbidity, therefore, between insomnia and 
depression may be a function of the overlapping diagnostic criteria. However, more 
recent theories conceptualize insomnia as more than simply a symptom of depression. 
Some speculate that the common co-occurrence between insomnia and depressive 
symptoms may be a function of the influence of poor sleep on other depressive 
symptoms, such as negative mood, irritability, decreased motivation, and difficulty with 
attention and concentration (Smith, Huang, & Manber, 2005). Studies suggest that 
insomnia may be a risk factor for developing depression and may exacerbate depressive 
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symptoms, which may in turn intensify sleep problems, creating a vicious cycle 
(Stepanski & Rybarczyk, 2006). On the other hand, several studies have demonstrated 
that a single night of sleep deprivation in depressed patients dramatically improves mood 
.the next day (Wu & Bunney, 1990). In a longitudinal study of insomnia and depression 
spanning 20 years, Buysse and colleagues (2008) concluded that insomnia and depression 
are "commonly comorbid, but distinguishable, conditions." While some research 
suggests that sleep problems may precede depression (and vice versa), there may be a 
common underlying etiology between insomnia and depression. This chapter aimed to 
evaluate the extent to which genetic and environmental influences contribute to the 
comoribidy of insomnia and depression through structural equation twin modeling. 
Methods 
Participants 
All subjects in this study are VETSA participants. Data collected during VETSA 
(2003-2007) and during the Harvard Drug Study (1991-1993) were used in this study. 
Assessments 
The Pittsburgh Sleep Quality Index (PSQI). The PSQI was administered in 
VETSA and used to assess symptoms of insomnia. The PSQI is described in detail in 
Chapter 1, and the global PSQI score (continuous variable) was examined in this study. 
The Center for Epidemiologic Studies- Depression Scale (CES-D). The CES-
D was administered in VETSA (2003-2007) and used to assess symptoms of depression. 
This questionnaire consists of 20 questions concerning the frequency of specific moods 
and behaviors during the past week. Ratings are on a four point scale, from zero 
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(experienced the symptom less than one day during the past week) to three (experienced 
on five to seven days), which are totaled to provide a global score ranging from 0-60. A 
global CES-D score greater than or equal to 16 represents clinically significant 
psychological distress (Radolff, 1977). The measure has excellent reliability (alpha 
>0.92) and is considered a valid indicator of clinically meaningful depression (Rush et 
al., 2000). The global CES-D score (continuous variable) will be used in these analyses. 
The Diagnostic Interview Schedule Version III Revised (DIS-III-R) (Robins, 
1989). The DIS-III-R was administered in the Harvard Drug Study (1991-1993) and used 
to assess lifetime diagnosis of depression and other psychiatric disorders. This is a 
structured interview performed over telephone by the Institute for Survey Research at 
Temple University. Responses to the DIS-III-R were used to diagnose depression 
according to the revised third edition of the Diagnostic and Statistical Manual of Mental 
Disorders (DSM-III-R). Interviewers assessed for current and past episodes of 
depression, and lifetime symptom counts from the DSM-III-R and depression diagnosis 
were available in the current study. 
Data Analysis 
All assessment measures were treated as continuous variables. Scores on the 
PSQI, CES-D, and DSM-III-R symptom counts were positively skewed, with estimates 
of skewness and standard errors of 1.12 (.07), 1.79 (.07), and 1.29 (.07), respectively. A 
square root transformation was applied to the data to achieve a normal distribution. The 
extent to which shared genetic and environmental factors influence symptoms of 
insomnia and depression were examined using three different approaches. First, I 
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examined scores on the PSQI and CES-D, which were both assessed at the same time 
during VETSA. Second, since sleep problems are a symptom of depression, I examined 
scores on the PSQI and CES-D after controlling for an insomnia-related question on the 
CES-D. Of the 20 questions on the CES-D, one question assessed for sleep difficulty 
("my sleep was restless"). This question was eliminated from the analysis, as it may 
inflate the phenotypic correlation between measures of insomnia and depression and 
influence estimates of shared familial vulnerability. Since scores on the PSQI and CES-
D capture symptomatology over the past month and week, respectively, I also examined 
the relationship between PSQI scores (assessed in VETSA between 2003-2007) and 
DSM-III-R symptom counts of ever having depression (assessed in the HDS between 
1991-1993). 
Analyses were performed using the structural equation modeling software 
package Mx (Neale et al., 2003). As described in Chapter 2, this type ofbiometrical 
modeling is used to quantify genetic and environmental determinants of traits and 
assumes that the observed variation in a trait is due to the contributions of shared genes 
(A), the shared/common environment (C), and non-shared environment (E). 
Three types of correlations in MZ and DZ twin pairs were used: phenotypic 
correlations examining the association of two traits within an individual, twin correlations 
for a single trait (e.g., insomnia in twin 1 with insomnia in twin 2), and cross-twin cross-
trait correlations (e.g., insomnia in twin 1 with depression in twin 2). In addition to the 
A, C, and E parameters estimated in the univariate model, the bivariate correlated factors 
model adds correlations between latent variables, rA, rC, andrE, which represents the 
genetic correlation, the shared environmental correlation, and the non-shared 
environmental correlation, respectively. Larger MZ than DZ cross-twin cross-trait 
correlations are indicative of a common genetic influence on both phenotypes. 
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I first fit a saturated model that captures the observed data perfectly and then 
tested whether more parsimonious models could account for the data without a significant 
reduction in fit. The full model (ACE) and reduced models that delete eitherA or C 
effects were compared to the saturated model. All models were fit to the raw data by 
means of maximum likelihood. A chi -square difference test was used to assess whether a 
reduced model fits the data better or worse than the full model. This is obtained by 
comparing the difference in -2 log likelihood (-2LL) for each sub-model (through the 
likelihood-ratio statistic). The Akaike Information Criteria (AIC) (Akaike, 1987) was 
also used to identify the goodness of fit and parsimony; the more negative the AIC, the 
better the balance between the two. Of note, the present study did not use the 13 
comorbidity models proposed by Neale and Kendler (Neale & Kendler, 1995) since 
research has shown that this method does not always discriminate between alternate 
models, even in studies utilizing fairly large sample sizes (Rhee et al., 2004). 
Results 
During the Harvard Drug Study (1991-1993) when subjects were assessed for 
everhaving lifetime depression, subjects' ages ranged from 36-55 years (mean age 44.6, 
sd 2.8). Approximately 12 years later when subjects were assessed for current symptoms 
of insomnia (PSQI) and depression (CES-D) during the VETSA study (2003-2007), 
subjects' ages ranged from 51-60 years (mean age 55.6, sd 2.5). Among individuals from 
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the Harvard Drug Study who also participated in VETSA, lifetime DSM-III-R symptom 
counts of depression assessed at age 45 (on average) ranged from zero to nine, and the 
mean number of symptoms was 1.99 (s.d. 2.3). The mean global PSQI score was 5.62 
(s.d. 3.6), and the mean CES-D score was 8.26 (s.d. 8.15). 
Forty percent of subjects met the threshold for having clinically significant sleep 
problems, 15% of subjects met the CES-D threshold for having depression, and 9% of 
subjects met DSM-III-R diagnostic criteria for ever having depression. Forty percent of 
the sample had clinically significant sleep problems, and of this group, 27% had co-
occurring depression based on the CES-D criterion, and 14% of subjects had a lifetime 
DSM-III-R diagnosis of depression. Of the 15% of subjects with depression assessed 
with the CES-D in VETSA, 70% had co-occurring insomnia. Ofthe 9% of subjects with 
a lifetime DSM-III-R diagnosis of depression assessed from 1991-1993 in the HDS, one 
third had clinically significant sleep problems at the time of assessment during VETS A 
(2003-2007). Results, therefore, reflect a strong comorbidity between insomnia and 
depression. 
Phenotypic and Cross-Twin Cross-Trait Correlations 
There were no significant differences in scores on the PSQI, CES-D, and DSM 
symptom counts between MZ and DZ twins (p = .87, .93, and .93, respectively). The 
phenotypic correlation between symptoms of insomnia and co-occurring symptoms of 
depression (CES-D) was .48 (p < .001), and the phenotypic correlation was .49 (p < .001) 
after controlling for symptoms of insomnia on the CES-D. The phenotypic correlation 
between symptoms of insornilia (assessed between 2003-2007) and lifetime symptom 
counts of depression based on DSM-III-R diagnostic criteria (assessed between 1991-
1993) was .26 (p < .001). The correlation between lifetime symptom counts of 
depression and later CES-D score was .27 (p < .001). 
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Maximum likelihood estimates of correlations for MZ and DZ twins are provided 
in Table 3.1; these results indicate the principle trends in the data. The cross-twin 
correlations of scores on the PSQI, CES-D (with and without the question that assessed 
for restless sleep), and DSM-III-R symptoms for MZ twins are all greater than those for 
DZ twins, suggesting that genetic effects play some role in individual differences. 
The cross-twin cross-trait correlations for MZ twins are greater than those for DZ 
twins for scores on the PSQI and CES-D (with and without the question that assessed for 
restless sleep), suggesting that the genetic influences on both traits are correlated to some 
extent. The pattern of cross-twin cross-trait correlations is less clear for the PSQI and 
DSM-III-R symptom counts of depression. While the correlation between symptoms of 
insomnia in Twin 2 and symptoms of depression in Twin 1 is significant among DZ 
twins, the correlation between symptoms of insomnia in Twin 1 and depression in Twin 2 
is not significant. Similarly, while the correlation between symptoms of insomnia in 
Twin 1 and depression in Twin 2 among MZ twins is significant, the correlation between 
symptoms of insomnia in Twin 2 and symptoms of depression in Twin 1 among MZ 
twins is not significant. This is most likely a result of chance due to the random 
assignment to Twin 1 and Twin 2 status. 
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Univariate Genetic Analysis 
The extent to which genes and the environment contributes to the variability of 
symptoms of insomnia in this sample have been described in a Chapter 2. In brief, 
additive genes, the shared environment, and non-shared environment contributed to 28% 
(0-42), 5% (0-29), and 67% (60-77) ofthe variation in individual differences in 
symptoms of insomnia, respectively. The AE model, however, was the best model, with 
additive genes and the non-shared environment contributing to 34% (25-42) and 66% 
( 58-7 5) of the heritability of insomnia, respectively. A similar pattern of model fit was 
found for symptoms of depression. For the CES-D, A, C, and E estimates were 23% (0-
46), 15% (0-37), and 61% (53-71), respectively. Dropping C from the model improved 
the fit, and additive genes and the non-shared environment explained 40% (32-47) and 
60% (53-69) of the variance of depression, respectively. Based on the DSM-ITI-R 
symptom counts, A, C, and E estimates were 24% (0-36), 3% (0-22), and 73% (64-83), 
respectively. Dropping C from the model improved fit, and additive genes and the non-
shared environment explained 27% (18-36) and 73% (64-82) of the variance oflifetime 
depression, respectively. Model fit estimates are provided in Table 3.2 and univariate 
variance component estimates derived from the bivariate correlated factors models are 
provided in Table 3.3. 
Bivariate Genetic Analysis 
In the bivariate analysis of the PSQI and CES-D measures, the genetic correlation, 
shared environmental, and non-shared environmental correlation between symptoms of 
insomnia and depression was .60 (-1.0, 1.0), 1.0 (-.61, 1.0), and .36 (.27, .45), 
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respectively. The AE model provided the best fit, as indicated by a lower AIC value 
(AIC= -23.74 vs -28.13). In the AE model, the genetic correlation and the unique 
environmental correlation between symptoms of insomnia and depression was .71 (.57, 
.85) and .35 (.26, .43), respectively (Figure 3.1). A similar pattern was found between 
symptoms of insomnia and depression when omitting question 12 from the CES-D ("my 
sleep was restless"). 
In the bivariate analysis of the PSQI and DSM-III-R measures, the genetic 
correlation, shared environmental, and non-shared environmental correlation between 
symptoms of insomnia and lifetime depression was .36 (-1.0, 1.0), 1.0 (-1.0, 1.0), and .17 
(.08, .27), respectively. The AE model provided the best fit, as indicated by a lower AIC 
value (AIC= -24.07 vs -29.63). The genetic correlation and the unique environmental 
correlation between insomnia and depression was .46 (.24, .68) and .17 (.07, .26), 
respectively (Figure 3.2). The model fit estimates are provided in Table 3.3, and the 
bivariate correlations are provided in Table 3.4. 
Discussion 
Insomnia and depression are highly comorbid disorders, and the present study 
aimed to examine the extent to which their comorbidity is influenced by shared genetic 
and environmental effects. Results demonstrate that much of the same genetic influence 
on the variability of insomnia is also associated with depression, suggesting that the 
comorbidity between these two disorders is in part due to common genetic effects. The 
shared family environment did not significantly contribute to the variability of these 
disorders. Since some researchers argue that the high comoribidity may be due to 
overlapping diagnostic criteria, I also controlled for sleep~related questions when 
assessing co-occurring depression. Results show no differences in model fit or 
heritability estimates. 
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This is the first twin study to examine the shared familial vulnerability of 
insomnia and depression, although two previous studies have explored related constructs. 
One study (Paunio et al., 2009) assessed poor sleep and life dissatisfaction over time (in 
1975 and 1981). Sleep quality was dichotomized into two variables, optimal and non-
optimal sleep, and was measured by taking into account the number of hours of sleep and 
by asking: "Do you usually sleep well (with 5 response alternatives)?" The most 
parsimonious univariate model of sleep quality included additive genetic and unique 
environmental effects. For men, the heritability estimates were 33% in 1975 and 39% in 
1981, and for women, they were 53% in 1975 and 39% in 1981. Life dissatisfaction was 
assessed using a questionnaire that focused on feelings of loneliness, difficulties in life, 
happiness, and anhedonia. A predictive relationship was found between poor sleep 
quality and subsequent life dissatisfaction. The authors examined whether covariation 
between poor sleep and life dissatisfaction could be accounted for by shared genetic 
influences using multivariate structural equation analyses. Results of this study did not 
suggest a significant shared genetic influence on the cross-twin cross-trait correlations of 
sleep quality in 1975 and life dissatisfaction in 1981 (.21 for men and .27 for women), 
suggesting that the phenotypic correlation likely reflects a causal relationship between 
poor sleep and life dissatisfaction. 
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A second twin study examined chronic fatigue and anxiety and depression (Roy-
Byrne et al., 2002). Chronic fatigue was measured by asking "Have you been fatigued 
for at least 6 months?" Mood and anxiety symptoms were assessed through a structured 
interview and the General Health Questionnaire (GHQ). Results show that while subjects 
with chronic fatigue have significantly increased symptoms of psychological distress, the 
relationship between fatigue and depression was not due to common genetic influences. 
The two twin studies described above found primarily independent genetic 
influences on constructs related to insomnia and depression (i.e., poor sleep and life 
dissatisfaction; chronic fatigue and depression). Since these studies did not specifically 
examine insomnia and depression, it is not particularly surprising that these results are 
quite different from fmdings in the present study which suggests that symptoms of 
insomnia and depression are largely due to the influence of shared genes. There may be a 
unique comorbid relationship, therefore, between insomnia and depression that is 
etiologically distinct from chronic fatigue and depression. Interestingly, while the 
heritability estimate of symptoms of insomnia in the present study is consistent with the 
estimate for men presented by Paunio et al. (2009) (34% and 33-39%, respectively), 
results are inconsistent regarding the extent to which these genetic effects are shared with 
depression or life dissatisfaction. One explanation is that depression and life 
dissatisfaction, while related, are different constructs. Second, the assessment of 
insomnia in the present study is very different from the measure of sleep problems used 
by Paunio and colleagues (2009). While Paunio et al. (2009) assessed poor sleep by only 
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one question, "do you usually sleep well?", the measure of insomnia in the present study 
(PSQI) is more comprehensive (Buysse et al., 1989). 
Nature of the relationship between insomnia and depression 
Results demonstrating that the genetic influences on depression and insomnia are 
in part due to shared genes may be a reflection of shared endophenotypes that influence 
the development of both disorders, such as underlying temperament and cortisol 
regulation, which may be more closely related to genetic liability. Common personality 
traits influence the development ofboth insomnia and depression. Studies of the 
relationship between temperament and insomnia have found that harm avoidance is 
significantly higher in patients with chronic insomnia (as measured by polysomnography) 
compared to controls (de Saint Hilaire, Straub, & Pelissolo, 2005). Similarly, fmdings 
have demonstrated a significant relationship between harm avoidance and major 
depressive disorder (Celikel et al. , 2009). Both of these studies utilized Cloninger's 
psychobiological model of temperament and character (Cloninger, Svrakic, & Przybeck, 
1993). 
Alterations in cortisol have also been demonstrated in patients with insomnia 
(Rodenbeck et al. , 2002) and depression (Stroble & Holsboer, 2003). Cortisol is a 
corticosteroid hormone produced by the adrenal cortex and is involved in response to 
stress and anxiety. Cortisol has been found to be significantly influenced by additive 
genes, and in a meta-analysis of five twin studies, the heritability of basal cortisol levels 
was found to be 62% (Bartels, Van den Berg, Sluyter, Boomsma, & de Geus, 2003). 
Twin studies have also demonstrated a genetic predisposition to high cortisol reactivity in 
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response to stressors in children (Federenko, Nagamine, Hellhammer, Wadhwa, & Wust, 
2004; Ouellet-Morin et al., 2008; Steptoe, van Jaarsveld, Semmler, Plomin, & Wardle, 
2009), which may lead to susceptibility to developing disorders such as insomnia and 
depression. Studies have also demonstrated that premorbid differences in HP A axis 
function prospectively predict the onset of adolescent depression (Adam, Sutton, Doane, 
& Mineka, 2008), suggesting that cortisol may contribute to the etiology of depressive 
symptoms (Mcisaac & Young, 2009). Several twin studies have examined cortisol 
hyperactivity as a potential endophenotype of depression. In twin pairs discordant for 
depression, such studies have found that non-proband co-twins also demonstrated an 
altered cortisol profile compared to control twins, suggesting that cortisol is a likely 
endophenotype (Vinberg, Bennike, Kyvik, Andersen, & Kessing, 2008; Wichers et al., 
2008). While some studies have demonstrated that insomnia is related to increased 
cortisol, no family or twin study to date has examined cortisol as an endophenotype of 
insomnia. Cortisol hyperactivity and reactivity, therefore, may underlie the development 
of insomnia and depression and is more closely linked to genetic influences than either 
disorder phenotype, possibly explaining the shared genetic influences on insomnia and 
depression. 
Implications for treatment 
Examining the shared genetic and environmental influences of insomnia and 
depression may help to inform treatment approaches and elucidate findings from previous 
treatment outcome studies. Such studies have demonstrated an association between 
insomnia and reduced response to treatment for depression (Reynolds et al., 1997). 
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Similarly, treating patients with comorbid insomnia and depression using only cognitive 
. behavioral therapy techniques for insomnia (CBT-1) significantly reduced depressive 
symptomatology (Manber et al., 2008; Taylor, Lichstein, Weinstock, Sanford, & Temple, 
2007), suggesting that depression may improve secondarily to treating sleep problems. In 
addition, research has reported that a disturbed sleep pattern is a better predictor of poor 
response to psychotherapy for depressed patients than the severity of depression (Thase et 
al., 1997). Studies have also demonstrated that certain antidepressant medications can 
improve sleep architecture (Holshoe, 2009). In sum, previous studies have demonstrated 
that treating one disorder often leads to improvements in the other disorder. It is possible 
that treatment for a specific disorder may influence common underlying endophenotypes, 
such as personality styles or cortisol, which may then lead to secondary improvements in 
the other disorder. However, it is important to note that less than half of the variability of 
insomnia and depression is due to additive genetic effects. An individual's unique 
environment has the strongest influence on the variability of these disorders, so 
considering the unique factors that might influence insomnia and depression in clinical 
practice is clearly valuable. 
Limitations 
This study has several limitations. Lifetime depression was assessed over ten 
years prior to assessing insomnia. Individuals who developed depression during this ten 
year period may have been left out ofthe analysis, possibly explaining the smaller 
phenotypic correlation between insomnia and lifetime depression (r = .26) compared to 
insomnia and co-occurring depression (r = .51). The higher prevalence of having current 
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depression (15%) compared to ever having depression (9%) may also reflect a limitation 
in assessments, since the DSM definition is more stringent compared to the CES-D. 
Furthermore, the PSQI and CES-D are one time assessments of insomnia and 
depression, measuring sleep problems and symptoms of depression over the preceding 
month and week, respectively. These disorders, however, may be transient, and the use 
of cross-sectional data likely omits important information. As described in Chapter 2, 
previous reports indicate that the PSQI is a stable measure of sleep quality over the 
course of a year (Knutson et al., 2006). Limitations related to the PSQI and the exclusion 
of women are discussed in Chapter 2. 
Despite these shortcomings, this study significantly contributes to the field. 
Common genetic influences on insomnia and depression have been identified, suggesting 
that the co-occurrence of these disorders is largely due to shared genes. Future 
investigations should focus on the role that genes play in influencing the high 
comorbidity of insomnia and depression through the examination of potential shared 
endophenotypes, such as personality traits and cortisol. Since the present study used 
baseline data of a longitudinal study of aging (VETSA), future studies should also 
examine the extent to which genetic and environmental influences on the relationship 
between insomnia and depression change over time. 
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Table 3.1. 
Phenotypic correlations for insomnia and depression. 
Correlations examining the association of insomnia (PSQI score) and depression within 
an individual, twin correlations for a single trait, and cross-twin cross-trait correlations 
are presented. 
Twin 1 PSQI Twin2 PSQI Twin 1 CES-D 
Monozygotic Twins 
Twin 2 PSQI .35 
Twin 1 CES-D .48 .28 
Twin 2 CES-D .31 .55 .41 
Dizygotic Twins 
Twin 2 PSQI .19 
Twin I CES-D .40 .20 
Twin2 CES-D .18 .53 .26 
Twin 1 PSQI Twin 2 PSQI Twin 1 modified CES-D 
Monozygotic Twins 
Twin 1 modified CES-D .48 .28 
Twin 2 modified CES-D .31 .56 .40 
Dizygotic Twins 
Twin I modified CES-D .40 .20 
Twin 2 modified CES-D .19 .54 .25 
Twin 1 PSQI Twin 2 PSQI Twin 1 DSM-III-R 
Monozygotic Twins 
Twin I DSM-III-R .26 .08 (p=.IS) 
Twin 2 DSM-III-R .23 .34 .22 
Dizygotic Twins 
Twin I DSM-III-R .24 .18 
Twin 2 DSM-III-R .002 (p=.97) .21 .12 
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Note. p < .01 for all correlations unless othetwise specified in the table. Modified CES-
D= overall score on the CES-D after taking out question 12, "my sleep was restless," 
DSM-III-R= symptom counts of depression outlined in the DSM-III-R, assessed using 
the DIS-III-R in the Harvard Drug Study. 
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Table 3.2. 
Bivariate model fit estimates for insomnia and depression. 
Results from the saturated model that capture the observed data perfectly and more 
parsimonious models are displayed. The lower AIC value reflects the best model that can 
account for the data without a significant reduction in fit. 
-2LL df A df A chi-sq p value AIC 
PSQI and CES-D 
Saturated Model 6502.80 2629 1764.80 
ACE 6517.06 2388 19 14.27 .77 -23.74 
AE 6518.67 2391 22 15.87 .82 -28.13 
CE 6522.75 2391 22 19.95 .59 -24.05 
PSQI and modified CES-D 
Saturated Model 6423.05 2369 1685.06 
ACE 6437.84 2388 19 14.79 .74 -23.22 
AE 6439.36 2391 22 16.30 .80 -27.70 
CE 6443.83 2391 22 20.78 .54 -23.23 
PSQI and DSM-lli-R 
Saturated Model 5839.04 2419 1001.04 
ACE 5852.97 2438 19 13.93 .79 -24.07 
AE 5853.41 2441 . 22 14.31 .89 -29.63 
CE 5860.14 2441 22 21.10 .51 -22.90 
Note. Modified CES-D= overall score on the CES-D after taking out question 12, "my 
sleep was restless," DSM-III-R= symptom counts of depression outlined in the DSM-III-
R, assessed using the DIS-111-R, A= additive genetic influences, C= common/shared 
environmental influences, E= non-shared environmental influences, -2LL= -2 log 
likelihood, df= degrees of freedom, AIC= Akaike's Information Criterion. 
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Table 3·3· Univariate variance component estimates for insomnia and depression. 
Heritability Common/Shared Non-shared 
Environment Environment 
a 2 (95% Cl) c2 (95% Cl) e2 (95% CI) 
PSQI ACE .28 (.00, .42) .05 (.00, .29) .67 (.60, .77) 
AE .34 (.25, .42) .66 (.58, .75) 
CE .27 (.19, .34) .73 (.66, .81 ) 
CES-D ACE .23 (.00, .46) .15 (.00, .37) .61 (.53 , .71) 
AE .40 (.32, .48) .60 (.52, .68) 
CE .34 (.26, .41) .66 (.59, .74) 
Modified CES-D ACE .24 (.00, .46) .14 (.00, .36) .62 (.54, .71) 
AE .39 (.31, .47) .61 (.53, .69) 
CE .33 (.25, .40) .67 (.60, .75) 
DSM-III-R depression ACE .24 (.00, .36) .03 (.00, .22) .73 (.64, .83) 
AE ;27 (.18, .36) .73 (.64, .82) 
CE .21 (.13 , .28) .79 (.72, .87) 
Note. Modified CES-D= overall score on the CES-D after taking out question 12, "my 
sleep was restless," DSM-III-R= symptom counts of depression outlined in the DSM-III-
R, A= additive genetic influences, C= common/shared environmental influences, E= non-
shared environmental influences, a2 = the amount of variability of insomnia/depression 
explained by additive genetic influences, c2: = the amount of variability of insomnia/depression 
explained by common environmental influences, e2= the amount of variability of 
insomnia/depression explained by non-shared environmental influences, CI= confidence interval. 
Table 3.4. 
Bivariate correlation estimates for variance components. 
Additive genetic, common/shared environmental, and non-shared environmental 




rA (95% CI) rC (95% CI) 
PSQI and CES-D (phenotypic correlation= .48) 
ACE .60 ( -1.0, 1.0) 1.0 (.59, 1.0) 
AE .71 (.57, .85) 
CE .73 (.59, .87) 




.61 ( -1.0, 1.0) 
.73 (.59, .87) 
1.0 (.49, 1.0) 
.75 (.61 , .89) 




.36 ( -1.0, 1.0) 1.0 ( -1.0, 1.0) 
.46 (.24, .68) 




rE (95% CI) 
.36 (.27, .45) 
.35 (.26, .43) 
.38 (.30, .45) 
.36 (.27, .44) 
35 (.26, .43) 
.37 (.30, .44) 
.17 (.08, .27) 
.17 (.07, .26) 
.18 (.10, .26) 
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Note. Modified CES-D= overall score on the CES-D after taking out question 12, "my 
sleep was restless," DSM-III-R= symptom counts of depression as outlined in the DSM-
III-R, A= additive genetic influences, C= common/shared environmental influences, E= 
non-shared environmental influences, CI= confidence interval. 
Figure 3.1. 
The full (ACE) and best-fitting (AE) model of insomnia and co-occurring depression. 
Insomnia 
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.71 (.59, .87) 
Insomnia 
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1 .0 (-.61 , 1.0) .36 (.27, .45) 






Note. A= additive genetic influences, C= common environmental influences, E= unique 
environmental influences. Values adjacent to the lines are standardized variance 
components, and values in parenthesis are 95% confidence intervals for the standardized 
variance components. a2= proportion of variance due to genetic influences, c2= 
proportion of variance due to shared environmental influences, e2= proportion ofvariance 
due to non-shared environment. Values in brackets are path coefficients. 
Figure 3.2. 
The full (ACE) and best-fitting model (AE) of insomnia and lifetime depression. 
e2=.67 
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Note. A= additive genetic influences, C= common environmental influences, E= unique 
environmental influences. Values adjacent to the lines are standardized variance 
components, and values in parenthesis are 95% confidence intervals for the standardized 
variance components. a2= proportion of variance due to genetic influences, c2= 
proportion of variance due to shared environmental influences, e2= proportion of variance 
due to non-shared environment. Values in brackets are path coefficients. 
CHAPTER 4: Insomnia, depression, and cognitive functioning 
Introduction 
As described in Chapter 3, insomnia and depression are highly comorbid 
disorders with common genes that influence the variability of each disorder. Since 
insomnia and depression are also associated with impairments in cognitive functioning, 
further delineation of the inter-relationships between sleep and depression on cognitive 
performance is warranted. 
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Adults presenting with insomnia and related sleep complaints exhibit impairments 
in many cognitive domains, including working and long-term memory, set shifting, 
abstract problem solving, visual spatial reasoning, learning, attention, and concentration 
compared to good sleepers (Bastien et al., 2003; Nebes et al., 2009; Szelenberger & 
Niemcewicz, 2000). The vast majority of studies that examine cognitive performance 
among individuals with insomnia have controlled for possible confounders such as 
depression. Results from these studies, however, are largely conflicting, and there is little 
evidence of a single and consistently reported cognitive deficit in insomnia patients 
(Fulda & Schulz, 2001; Shekleton et al., 20 10). 
A recent paper reviewed studies of cognitive functioning in patients with primary 
insomnia of all ages to assess the effects of insomnia on cognition independent from 
medical or psychiatric disorders that would account for sleep problems (Shekleton et al., 
201 0). This was controlled for in each study included in the review by carefully 
assessing and screening participants. The authors concluded that while this body of 
literature is largely inconsistent, individuals with insomnia performed worse on tasks of 
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working memory and attention compared to the control group more often than not. 
Specifically for tests of attention, deficits were observed in studies that used more 
complex tasks, such as shifting attention and making decisions in response to target and 
non-target stimuli, whereas deficits were not observed in sustained attention tasks that do 
not require decision-making (Altena, VanDerWerf, Strijers, & Van Someren, 2008; 
Shekleton et al., 2010). Research suggests that individuals with sleep problems have a 
reduced capacity to perform on tasks that require more cognitive resources and involve 
decision making (Altena, VanDerWerf, Strijers, & Van Someren, 2008). 
The majority of studies of individuals with insomnia do not report deficits in tasks 
of psychomotor speed, visual and verbal memory, and executive functioning (Shekleton 
et al., 201 0). While numerous studies have found that sleep in healthy participants is 
related to memory consolidation (Ficca & Salzarulo, 2004), only several studies have 
examined the relation between primary insomnia and memory consolidation (Backhaus et 
al., 2006; Nissen et al. , 2006). These studies support findings from studies of healthy 
subjects under sleep restriction conditions and memory consolidation, suggesting a 
relationship between insomnia and deficits in memory consolidation. 
Understanding the effects of insomnia and related sleep problems on cognition 
among older adults is significant given the increased incidence of insomnia with age and 
the importance of cognitive preservation in aging. Studies of older individuals have 
consistently found that insomnia and related sleep problems are associated with measures 
of general cognitive ability. Individuals with chronic insomnia (age 65 and older) 
demonstrated general cognitive decline over a three year period (assessed through the 
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Pfeiffer's Short Portable Mental Status Questionnaire) compared to participants without 
insomnia (Cricco, Simonsick, & Foley, 2001). Furthermore, sleep efficiency, latency, 
waking after sleep onset, and napping, but not total sleep time, predicted lower cognitive 
functioning (assessed using the Mini-Mental State Examination and Trail Making B Test) 
in elderly women (mean age 83.5) (Blackwell et al., 2006). Interestingly, other studies 
have found that while sleep disturbances are correlated with many cognitive doinains, 
total sleep duration is not, suggesting that the quality of sleep is more important than the 
amount of sleep that one obtains (Schmutte et al., 2007). 
Older adults with insomnia (age 65 and older) demonstrate impairments in 
domains of the "MindFit" test, including memory span, attention, time estimation, 
working memory, and integration of two dimensions (visual and semantic) (Haimov, 
Hanuka, & Horowitz, 2008) and with visual processing impairments (Haimov, Hadad, & 
Shurkin, 2007). In a study of older adults with chronic insomnia, impairments were 
found in attention/concentration tasks but not in tests of memory, psychomotor speed, 
and executive functioning (Vignola, Lamoureux, Bastien, & Morin, 2000). Objective 
measures of sleep in drug-free elderly insomniacs revealed that difficulty initiating sleep 
was associated with impaired performance on tasks of verbal memory and attention and 
concentration, whereas sleep fragmentation was associated with impaired psychomotor 
speed (Bastien et al., 2003). One study assessed insomnia using the PSQI and found that 
good and poor sleepers differed on tests of working memory, attentional set shifting, and 
abstract problem solving but not on processing speed, inhibitory function, or verbal 
episodic memory (Nebes et al., 2009). While insomnia and related sleep problems are 
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consistently found to influence general cognitive functioning in older adults, the 
influence of sleep on specific cognitive domains is less clear. More research, therefore, is 
needed to elucidate the effects of symptoms of insomnia on cognitive functioning both in 
the general and older adult populations. 
The relation between depression and cognitive impairments has been examined 
extensively, and converging results support the association between depression and 
numerous cognitive domains. Executive function deficits such as planning, set shifting, 
cognitive inhibition, flexibility, working memory, and organizing in older adults with 
clinical or subclinical depression are consistently reported (Baune; Suslow, Arolt, & 
Berger, 2007; Cui, Lyness, Tu, King, & Caine, 2007; Dotson, Resnick, & Zonderman, 
2008; Herrmann, Goodwin, & Ebmeier, 2007; Lessov-Schlaggar, Swan, Reed, Wolf, & 
Carmelli, 2007; Rabbitt, Lunn, Ibrahim, Cobain, & Mcinnes, 2008). Processing speed 
and memory deficits are found in many but not all studies of depressed older adults (Cui, . 
et al., 2007; Herrmann, et al., 2007), while other researchers report global, non-specific 
cognitive impairment (Reppermund, Ising, Lucae, & Zihl, 2009). In a meta-analysis of 
the relationship between depression and cognition, depression was associated with 
executive function, processing speed, episodic memory, and semantic memory 
(Herrmann et al., 2007). The overwhelming majority of these studies, however, do not 
control for the effects of insomnia or related sleep problems. 
This chapter aimed to examine the impact of insomnia on cognitive functioning, 
as studies to date report largely inconsistent results. The inter-relationship between 
insomnia, depression, and cognitive functioning was also examined. In a VETS A study, 
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Franz and colleagues (submitted for publication) found that depression symptoms were 
related to poorer visual spatial memory, short term memory, working memory, executive 
function, visual spatial processing, and general cognitive ability, after controlling for age, 
early cognitive ability (AFQT score at age 20), and health characteristics. Depression 
symptoms were not related to processing speed or verbal memory. This chapter will 
build upon Franz et al. 's study by controlling for symptoms of insomnia when examining 
the relation between depression and cognition. 
Methods 
Participants 
All participants in this study are from the Vietnam Era Twin Study of Aging, 
described in Chapter 1. 
Assessments 
The Pittsburg Sleep Quality Index (PSQI). The PSQI is described in detail in 
Chapter 1 and was used to assess insomnia. This study utilized the global PSQI score 
and the dichotomized PSQI variable (a score of six or above) in the analyses. 
The Center for Epidemiologic Studies- Depression Scale (CES-D). The CES-
D is described in detail in Chapter 3 and was used to assess depression. The total score 
on the CES-D was used in the analyses. 
Cognitive Measures. The VETSA test battery emphasized the cognitive domains 
of processing speed, visual spatial processing, visual spatial memory, immediate and 
delayed verbal memory, short term memory, working memory, and executive 
functioning. Multiple measures were used within each domain. Tests were carefully 
selected to avoid ceiling effects in middle-aged adults, and thus be more sensitive to 
change. 
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General cognitive ability was assessed with the Armed Forces Qualification Test 
(AFQT Form 7 A), a 50-minute paper and pencil test with 100 multiple-choice items. The 
same version of the AFQT had also been administered to the sample 35 years previously, 
just prior to military induction following the same standardized instructions (Orme, 
Brehm, & Ree, 2001; Uhlaner, 1952). The AFQT is highly correlated (r=0.84) with 
measures of general cognitive ability such as the Wechsler Adult Intelligence Scale 
(Wechsler, 1997a). Four areas of cognitive functioning (vocabulary, arithmetic word 
problems, visual spatial processing, and knowledge and reasoning about tools and 
mechanical relationships) are equally represented in the AFQT. 
Immediate and delayed episodic memory were assessed with two measures: the 
Wechsler Memory Scale-III (WMS-IID (Wechsler, 1997b) Logical Memory and Visual 
Reproductions tests. Logical Memory consists of two stories read to participants for 
immediate and delayed free recall. In the standard administration, the second story is 
presented twice prior to the delayed recall, but it was presented only once prior to the 
delay condition in our administration. Visual Reproductions consists of five designs that 
are presented for 10 seconds each and then drawn from memory for immediate and 
delayed recall. 
Processing speed was assessed with the Delis-Kaplan Executive Function System 
(D-KEFS) Trail Making Test condition 2 (number sequencing) and condition 3 (letter 
sequencing) (Delis, Kaplan, & Kramer, 2001) and the Stroop word reading condition 
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(Golden, 1978; Stroop, 1935). Unlike the traditional Trail Making Test, D-KEFS Trails 
has five conditions and stimuli are presented on double-sized pages. Scores used were 
time in seconds to complete each condition. The Stroop processing speed score was the 
number of words read correctly in the 45 second time limit. 
Multiple measures of executive function were administered including the D-
KEFS Trails condition 4 (number-letter switching), Verbal Fluency (letter and category 
fluency, category switching), and the Stroop color-word interference condition. These 
tests evaluate dimensions of set shifting, cognitive flexibility, and response inhibition-
all key elements of executive function. Time to complete Trails (in the numeric or letter 
conditions alone) was adjusted for in the letter-number switching condition. Word 
production was measured in the verbal fluency category (animal fluency) and category 
switching tasks (e.g., a fruit word followed by a furniture word). Fluency on the 
switching task was adjusted by the score on the animal fluency test. The Stroop 
interference condition score was adjusted for Stroop word reading performance. 
Short-term and working memory were assessed with three measures from the 
WMS-ill: Digit Span (forward and backward); Letter-Number Sequencing (re-
sequencing lists ofletters and numbers); and Spatial Span (forward and backward). 
Visual spatial processing measures included the Matrix Reasoning subtest from 
the Wechsler Abbreviated Scale of Intelligence (WAS I) (Wechsler, 1997 a), Thurstone ' s 
adaptation of the Gottschaldt Hidden Figures Test(GHFT) (Thurstone, 1944), and the 
Card Rotation test (Ekstrom, French, & Harmon, 1976). In the Matrix Reasoning test, 
participants identify the correct solutions for each of 35 increasingly difficult pattern sets. 
62 
The GHFT requires that the person identify figures that are embedded in more complex 
geometric figures. In the Card Rotation test participants determine whether rotated 
figures are the same as or different from a target figure. Both Hidden Figures and the 
Card Rotation tests are timed tests. For each visual spatial test, the score was the number 
of correct items. 
Individual measures were standardized and averaged in order to create seven 
cognitive domain scores: 1) Processing Speed (Trails 2 and 3, Stroop Word); 2) Verbal 
Memory (Logical Memory immediate and delayed, Logical Memory delayed adjusted for 
immediate); 3) Visual Spatial Memory (Visual Reproductions immediate and delayed, 
Visual Reproductions delayed adjusted for immediate); 4) Short-Term Memory (Digit 
Span forward and backward; Spatial Span forward and backward); 5) Working Memory 
(Digit Span Backward adjusted for Digit Span forward; Letter-Number Sequencing 
adjusted for Digit Span Forward; Spatial Span backward adjusted for Spatial Span 
forward); 6) Executive Functions (Trails Switching adjusted for Trails 2; Trails 
Switching adjusted for Trails 3; Stroop Interference adjusted for Stroop Word, Verbal 
Fluency Category Switching adjusted for Animal Category fluency) ; and 7) Visual 
Spatial Processing (Hidden Figures, Card/Mental Rotations, Matrix Reasoning). 
Analyses were conducted with domain measures. 
Health and lifestyle covariates. In other studies, age, cardiovascular risks, 
hypertension, diabetes, sleep apnea, and lifestyle factors such as smoking, drug use, and 
alcohol consumption are commonly included as covariates due to their association with 
insomnia, depression, brain aging, and cognition (Barnes, Alexopoulos, Lopez, 
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Williamson, & Yaffe, 2006; Elwood et al., 1999; Paul et al., 2008). These data were 
available from the medical history interview conducted on the day of testing. 
Cardiovascular risk factors were coded as present or absent based on responses to 
questions about whether a physician had told them they had a heart attack or currently 
have heart failure, peripheral vascular disease, hypertension, or angina. Diabetes and 
sleep apnea was defined as whether a participant reported that they had been diagnosed 
with either of these disorders. Smoking was based on whether participants reported that 
they currently smoked. An indicator of the presence of psychiatric disorders was based 
on participants' responses to questions regarding whether a physician had told them they 
had drug or alcohol abuse/dependence. 
Data analyses 
Generalized estimating equations (GEE) using SPSS were performed in which the 
separate cognitive domains were the outcome measures. GEE allows for correlated error 
terms between observations. While GEE is widely used for non-independence of 
repeated observations in time series analysis, this procedure was used in this study to 
control for non-independence of the pairs of twins. GEE has been validated for use in 
twin studies (Carlin, Gurrin, Sterne, Morley, & Dwyer, 2005), and estimates from GEE 
can be interpreted as if they were estimates from a standard regression model. 
To examine the effects of insomnia on cognitive performance, two increasingly 
complex models were systematically performed, with the subsequent model including 
variables from the previous model. Model 1 adjusted for age and early cognitive ability 
(AFQT from age 20), and Model 2 additionally adjusted for all health characteristics, 
including diabetes, sleep apnea, hypertension, angina, heart failure, peripheral vascular 
disease, alcohol and drug abuse/dependence, and smoking. To examine whether 
symptoms of depression mediate the relationship between insomnia and cognitive 
performance, depression (score on the CES-D) was added to Modell and to Model2. 
Beta weights quantify the influence of each predictor. 
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Second, Franz et al.'s previous study on depression and cognition was expanded 
upon by examining whether symptoms of insomnia mediate the relationship between 
symptoms of depression on cognitive functioning. Again, two increasingly complex 
models were systematically performed. Modell adjusted for age, age 20 cognitive 
ability, and insomnia (PSQI score), and Model2 additionally adjusted for all other health 
characteristics described above. 
Results 
Table 1 displays unadjusted correlations between insomnia with health and 
cognitive measures. A higher insomnia score (unadjusted for covariates) was 
significantly correlated with having diabetes, hypertension, and angina. Higher PSQI 
scores were also significantly associated with a greater number of symptoms of 
depression and with having alcohol and drug abuse/dependency. Higher PSQI scores 
were not significantly correlated with sleep apnea, heart failure, peripheral vascular 
disease, and smoking. There was also no significant relationship between symptoms of 
insomnia and age, which may reflect the lack of variability of age in the sample (age 
ranged from 51-60 years old). Insomnia symptoms, unadjusted for any covariates, were 
significantly correlated with poorer performance on 8 out of 10 cognitive domains: 
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general cognitive ability at age 20 (AFQT at induction into the military), current general 
cognitive ability (AFQT in VETSA), processing speed, visual spatial processing, visual 
spatial memory, short term memory, working memory, and executive functioning. 
Insomnia symptoms were not associated with immediate and delayed verbal memory 
performance. 
Table 2 shows results for the generalized estimating equations in which prior 
cognitive ability and age were controlled for as fixed effects and family identifier was 
controlled for as a random effect. Insomnia was examined in two ways: as scores on the 
PSQI and as dichotomized into individuals with and without clinically significant sleep 
problems. Results are consistent between continuous and dichotomous measures of 
insomnia with the exception of executive functioning, in which a higher score oh the 
PSQI predicted poorer executive functioning performance, and having clinically 
significant sleep problems (dichotomized variable) was not related to executive 
functioning. Insomnia (both continuous and dichotomized) predicted poorer performance 
on all other cognitive outcomes with the exception of immediate and delayed verbal 
memory. Effect sizes were small but significant. When health characteristics were added 
to the model, the relationship between insomnia (continuous and dichotomous variables) 
and processing speed and between insomnia (continuous) and executive functioning were 
no longer significant. The relationship between insomnia and cognitive performance 
remained the same for all other cognitive outcomes after adding health characteristics to 
the model. 
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Table 3 shows results for the generalized estimating equations when symptoms of 
depression are added to each model. Insomnia predicted poorer performance on visual 
. spatial processing and visual spatial memory domains. Depression mediated the 
relationship between insomnia and all other cognitive domains that were previously 
associated with insomnia. When health characteristics were added to the model, they did 
not contribute to variance in the cognitive measures; the relationships between insomnia, 
depression, and cognitive performance remained the same. Results also did not differ 
between continuous and dichotomous measures of insomnia. 
The results in Table 4 built upon a previous study by Franz and colleagues who 
reported that depression (score on the CES-D) was related to AFQT, visual spatial 
processing, visual spatial memory, short term memory, working memory, and executive 
functioning. While Franz et al. adjusted for numerous health characteristics, they did not 
control for the effects of insomnia. In the present study, after symptoms of insomnia 
were included in the model (PSQI score), depression was significantly related to AFQT, 
working memory, and executive functioning (with and without controlling for health 
characteristics). Insomnia, therefore, mediated the relationship between depression and 
visual spatial processing, visual spatial memory, and short term memory. 
Discussion 
This study aimed to examine the relation between insomnia (assessed through 
both a continuous measure of sleep problems and using a cut-off score that closely 
reflects a diagnosis of insomnia) and cognition, as no pattern of consistent results has 
emerged across previous studies. Given the extremely high comorbidity between 
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insomnia and depression and the cognitive deficits related to both disorders, the study 
examined the inter-relationship between insomnia, depression, and cognitive functioning. 
In the simplest model that adjusted for age and early cognitive ability, results 
suggest no association between verbal memory and symptoms of insomnia, which is 
largely consistent with previous research. While some studies have reported a 
relationship between insomnia and verbal memory (Bastien et al., 2003), the majority of 
studies have not (Shekleton et al. , 2010; Vignola et al. , 2000). Of note, my results 
support fmdings from Nebes and colleague (2009), who utilized the same assessment of 
symptoms of insomnia (PSQI) and of verbal memory (WMS Logical Memory). 
The majority of studies that employed objective EEG measures of insomnia have 
also failed to demonstrate an association between immediate or delayed verbal memory 
and any sleep parameters (Goder, Scharffetter, Aldenhoff, & Fritzer, 2007; Szelenberger 
& Niemcewicz, 2000). One study, however, found a significant correlation between 
verbal memory consolidation and the duration of REM sleep in patients with insomnia 
(Backhaus et al., 2006) and another found a relation between sleep spindle activity and 
verbal memory (Clemens, Fabo, & Halasz, 2005), although the later used normal 
sleepers, not patients with sleep problems, who were exposed to sleep deprivation 
conditions. 
After controlling for health characteristics, age, and early cognitive ability, 
insomnia predicted poorer performance on general cognitive ability, visual spatial 
processing and memory, short term memory, and working memory domains. These 
68 
results might support compromised hippocampal functioning in insomnia since insomnia 
was related to the majority of the memory domains, with the exception of verbal memory. 
Insomnia was not related to verbal memory (as described above), processing 
speed, and executive functioning after controlling for all confounders. Consistent with 
these results, there is a lack of converging evidence in the literature for an effect of 
insomnia on psychomotor speed and executive functioning (Shekleton et al., 2010). 
Some researchers speculate that common qualities among individuals with insomnia, 
such as a high level of perfectionism and arousal, may mask cognitive impairments due 
to poor sleep, especially on tasks of executive functioning (Vincent & Walker, 2000). 
Prefrontal brain activation during an fl\.1RI verbal fluency task of executive functioning 
was compromised in the absence of a behavioral deficit among patients with primary 
insomnia compared to control subjects (Altena et al., 2008). Altena and colleagues 
suggest that although sleep problems may lead to brain processing deficits, individuals 
with insomnia may also have an increased capacity to compensate and overcome deficits, 
which may, in part, explain the relatively subtle and inconsistent findings of cognitive 
impairments. 
While most studies report no impairments in executive functioning among people 
with insomnia, such deficits are commonly found in healthy participants subjected to 
sleep deprivation conditions (Randazzo, Muehlbach, Schweitzer, & Walsh, 1998). Sleep 
deprivation studies typically involve more substantial sleep restriction (Vignola et al., 
2000) and a less variable patterns of sleep loss (Altena, VanDerWerf, Strijers, et al., 
2008) compared to insomnia. These differences in methodology, coupled with the fact 
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that insomniacs may tend to compensate more for the impact of poor sleep, may explain 
why studies of insomniacs often report more subtle cognitive deficits than sleep 
deprivation studies of healthy participants. 
Depression mediated the relationship between symptoms of insomnia and general 
cognitive ability, short term memory, and working memory but not between symptoms of 
insomnia and visual spatial abilities. Studies of patients with depression show that upon 
symptom remission, general cognitive ability often improves (Mandelli et al., 2006) 
whereas visual spatial abilities remain impaired (Bhalla et al., 2006). While certain 
cognitive abilities may be a state dependent sequelae of depression (i.e. , general cognitive 
functioning), deficits that persist after depressive symptom remission (i.e., visual spatial 
functioning) may reflect trait dependent deficits or more permanent consequences of 
depression. Another possibility is that persisting cognitive deficits may be better 
explained by processes related to, yet independent from, depressed mood, such as sleep 
problems. It has also been reported that in patients with depression, co-occurring sleep 
problems often persist even after depression has remitted (Greer, Kurian, & Trivedi, 
2010). Furthermore, the fmding that insomnia mediated the relationship between 
depression and visual spatial abilities suggests that visual spatial deficits observed in 
depression are best explained by symptoms of insomnia. 
Results of this study, therefore, suggest that insomnia influences visual spatial 
memory and processing abilities independent of depression and other confounders. The 
role of sleep on vision has been demonstrated in brain development in early life, in which 
sleep enhances plasticity in the visual cortex (Frank, Issa, & Stryker, 2001). Several 
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studies have reported deficits in visual spatial processing among adults with insomnia 
compared to controls. Insomniacs demonstrated deficits in integrating individual 
elements into a coherent pattern to process global structures (assessed by identifying a 
figure at either the global or local level; e.g., a large H made up of smaller Hs or a large 
H made up of smaller Ss) (Haimov et al. , 2007) and deficits in nonverbal abstract 
reasoning (Nebes et al., 2009). One study examined visual memory among patients with 
insomnia and chronic non-restorative sleep using polysomnography. Visual memory 
performance (assessed by the Rey-Osterreith Complex Figure Test recall) was correlated 
with total sleep time, duration of non-REM sleep, sleep efficiency, and number of non-
REM/REM sleep cycles from the night before (Goder et al., 2007). 
Further evidence for the role of insomnia on visual spatial abilities is provided 
through MRI studies. Individuals with primary insomnia demonstrated reduced gray 
matter in the left orbitofrontal cortex and the precuneus compared to controls (Altena et 
al., 2010). The precuneus is associated with mental imagery and episodic memory 
retrieval (Cavanna & Trimble, 2006). While the orbitofrontal area is typically associated 
with elements of executive function, such as decision making and problem-solving 
abilities (Bechara, Damasio, & Damasio, 2000), such skills are also recruited in tasks 
included in the visual spatial processing domain in VETSA, such as the W ASI Matrix 
Reasoning subtest. 
Research using normal sleepers and participants exposed to sleep restriction 
suggest a relation between visual spatial abilities and slow wave sleep (SWS), which 
tends to occur at the beginning of the night and is the deepest stage of non-REM sleep 
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(Gais & Born, 2004; Peigneux et al. , 2004; Yaroush, Sullivan, & Ekstrand, 1971). For 
example, in healthy elderly subjects (age 75-85) without depression, longer sleep onset 
latency was associated with poorer performance on tests of visual spatial reasoning. In 
EEG, fMRI, and PET studies, overnight retention of visually presented faces (Clemens et 
al. , 2005), declarative memory consolidation on a visual spatial memory task (Rasch, 
Buchel, Gais, & Born, 2007), and visual discrimination skill acquisition (Gais, Plihal, 
Wagner, & Born, 2000; Stickgold, James, & Hobson, 2000) were significantly correlated 
with non-REM and SWS. One study examining regional cerebral blood flow found that 
hippocampal areas that are activated during spatial learning were activated during 
subsequent slow wave sleep, and the amount of hippocampal activity expressed during 
slow wave sleep positively correlated with the improvement of performance in retrieval 
the next day (Peigneux et al. , 2004). Researchers used a topographical memory task in 
which subjects learned to find their way inside a complex three-dimensional virtual town. 
It is surprising that depression mediated the relationship between symptoms of 
insomnia and working memory given that previous research has usually demonstrated 
that insomnia is related to deficits in working memory, even after controlling for 
depression (Haimov et al., 2008; Nebes et al., 2009; Shekleton et al. , 2010; Vignola et al., 
2000). Working memory also remains impaired in patients with major depressive 
disorder after remission (Kaneda, 2009; Weiland-Fiedler et al. , 2004). More research, 
therefore, is needed to further understand the relation between insomnia, depression, and 
working memory. 
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The findings of an independent relation between insomnia and visual spatial 
abilities and between depression and general cognitive ability, working memory, and 
executive functioning may lead to future examination of the unique neuronal pathways 
associated with each disorder. Numerous fMRI studies have linked visual spatial abilities 
to brain regions including the precuneu~, inferior and superior parietal cortex, posterior 
parieto-occipital cortex, and hippocampal regions (Diekmann, Jurgens, & Becker, 2009; 
Ng et al. , 2001; Stylianou-Korsnes, Reiner, Magnussen, & Feldman, 2010). The 
independent relation between depression and working memory and executive functioning 
suggests a potentially unique relationship between depression and the dorsolateral 
prefrontal cortex, which is involved in both of these cognitive domains (Metzak et al., 
2010; Michels et al. , 2010; Paskavitz et al., 2010). Understanding underlying brain 
processes may provide insight into the development and course of these disorders and 
lead to more specific targets for cognitive preservation and rehabilitation among older 
adults. 
Research has demonstrated that deficient visual perceptual processing is one of 
the most prominent impairments in cognitive functioning among older adults (Walsh, 
1988). The independent relationship between visual spatial deficits and insomnia found 
in this study, even after controlling for age, has significant implications for older 
individuals. While slow wave sleep, which is associated with sleep onset latency, has 
been found to play a role in such cognitive deficits, more research should focus on the 
mechanisms by which insomnia is related to visual spatial functioning. Treating 
insomnia and related sleep problems might be an appropriate and successful intervention 
for older individuals who demonstrate visual spatial memory and processing 
impairments. Furthermore, focusing on decreasing sleep onset latency to impact SWS 
might have the greatest impact in treatment. 
73 
There are several methodological limitations that lead to barriers in making 
comparisons across studies of cognitive impairments in insomnia. First, the methods of 
assessing and defming insomnia and related sleep problems vary considerably and 
include assessment measures such as polysomnography, interviews and questionnaires, or 
more stringent DSM diagnostic criteria. As described previously, a diagnosis of 
insomnia cannot be made based on the PSQI, although a score of six or greater 
discriminates individuals with primary insomnia from controls with excellent sensitivity 
and specificity (Backhaus et al., 2002). In this study, the continuous measure of 
symptoms of insomnia and the dichotomized variable had similar impacts on cognitive 
functioning. Results may suggest, therefore, that different methods of conceptualizing 
insomnia are not a significant barrier in comparing results across studies. A second and 
more significant limitation is the array of different neuropsychological tests, with many 
studies utilizing one task to reflect cognitive functioning in a particular domain. A 
strength of this study is that many of the cognitive domain variables were derived based 
on performance on a large number of tests. Another limitation of this study is that 
measure~ of attention were not examined. While the VETSA n~uropsychological battery 
includes measures of attention, the data were not available for analysis at the time of this 
study. Data will be available, however, for future analysis. 
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Table 4.1. 















Age 20 Cognitive Ability 
AFQT Percentile 
Processing Speed 
Visual Spatial Processing 
Visual Spatial Memory 
Verbal Memory 
Verbal Memory Delay 
Short Term Memory 
Working Memory 
Executive Functioning 
Mean (SD) Correlation with p value 
PSQI score (r) 
5.60 (3 .60) 
8.26 (8.15) .51 <.001 
55 .6 (2.5) -.05 .12 
N(%) 
121 (9 .8) .08 .005 
66 (5.3) .02 .56 
421 (34.0%) .11 <.001 
16 (1.3%) .06 .05 
3 (.2%) .03 .32 
13 (1.1 %) .03 .30 
297 (24.0%) .07 .06 
9 (0.7%) .11 <.001 
2 (0.2%) .10 <.001 
N 
1195 -.07 .02 
1211 -.09 .002 
1205 -.09 .002 
1211 -.15 <.001 
1205 -.09 .001 
1202 .009 .75 
1211 -.001 .98 
1210 -.08 .004 
1209 -.08 .004 
1206 -.08 .004 
Note. SD= standard deviation 
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Table 4.2. 
Effect of insomnia on cognitive performance. 
Controlling for Age and Controlling for Age, Age 20 Cognitive Ability 
Age 20 Cognitive Ability and Health Characteristics 
Insomnia Symptoms Dichotomized Insomnia Insomnia Symptoms Dichotomized Insornnia 
Cognitive Domain N Estimate (SE) p Estimate (SE) p N Estimate (SE) p Estimate (SE) p 
General Cognitive Ability I 194 -0,07 (.03) .004 -0.12 (.04) .001 757 -0.08 (.03) .008 -0.16 (.05) .001 
Processing Speed 1188 -0.08 (.03) .004 -0.09 (.04) .04 742 -0.06 (.04) .10 -0.09 (.06) .II 
Visual Spatial Process ing I 194 -0.13 (.03) < .001 -0.20 (.04) < .001 747 -0.13 (.03) <.001 -0.19 (.05) <.001 
Visual Spatial Memory I 188 -0.09 (.03) .004 -0.13 (.05) .005 741 -0.10 (.04) .009 -0.12 (.06) .01 
Verbal Memory 1185 0.02 (.03) .43 0.07 (.05) .14 739 0.02 (.04) .64 0.07 (.06) .21 
Verbal Memory Delay 1194 0.01 (.03) .62 0.05 (.04) .23 748 0.01 (.04) .77 O.o? (.05) .12 
Short Term Memory I 193 -0.06 (.02) .03 -0.09 (.04) .02 746 -0.06 (.03) .04 -0.10 (.05) .02 
Working Memory 1192 -0.07 (.03) .009 -0.10 (.04) .01 745 -0.09 (.03) .008 -0.14 (.04) .005 
Executive Functioning 1189 -0.06 (.03) .02 -.05 (.04) .22 742 -0.02 (.04) .58 O.ot (.05) .89 
Note. Insomnia symptoms= PSQI score, age 20 cognitive ability= AFQT score at 
military induction, age 20 cognitive ability was not controlled for in the model when 
general cognitive ability (AFQT score in VETSA) was an outcome variable, p values and 
beta estimates reflect results of generalized estimating equations, health characteristics= 
diabetes, sleep apnea, hypertension, angina, heart failure, peripheral vascular disease, 
alcohol and drug abuse/dependence, and smoking. 
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Table 4.3. 
Relation between insomnia and depression on. cognitive peiformance. 
Controlling for Depress ion , Age, Controlling for Depress ion , Age, 
And Age 20 Cognitive Ability Age 20 Cognitive Ability, 
and Health Characteristics 
Insonmia Symptom> Dichotomized lnsonmia Insonmia Sy mptom; Dichotomized lnsonmia 
Cognitive Domains N Estimate (SE) p Estimate (SE) p N Estimate (SE) p Estimate (SE) p 
General Cognitive A bility 1143 0.02 (.03) .56 -0.03 (.04) .53 720 -0.003 (.04) .92 -0.07 (.05) .18 
Processing Speed 1038 -0.06 (.03) .09 -0.05 (.05) .25 706 -0.03 (.05) .49 -0.05 (.07) .44 
Vtsual Spatial Process ing 1043 -0. 11 (.03) <.001 -0.18 (.04) < .001 710 -0.10 (.04) .01 -0.17 (.06) .002 
Vtsual Spatial Memory 1138 -0.08 (.03) .03 -0.13 (.05) .008 705 -0.10 (.04) .02 -0.14 (.07) .04 
Verbal Memory 1136 0.04 (.03) .24 0.09 (.05) .07 703 0.05 (.04) .29 0.12 (.06) .06 
Verbal Memory Delay 1143 0.04 (.03) .20 0.08 (.04) .07 710 0.05 (.04) .22 0.13 (.06) .06 
Short Tenn Memory 1143 0,03 (.03) .27 -0.06 (.04) .16 710 -0.05 (.04) .21 0.09 (.05) .09 
Working Memory 1142 0.007 (.03) .80 -0.04 (.04) .34 709 -0.04 (.04) .28 -0.10 (.05) .08 
Executive Functioning 1139 -0.007 (.03) .82 -0.02 (.04) .60 706 0.04 (.04) .33 -0.07 (.06) .24 
Note. Insomnia symptoms= PSQI score, depression= CES-D score, age 20 cognitive ability= 
AFQT score at military induction, age 20 cognitive ability was not controlled for in the model 
when general cognitive ability (AFQT score in VETSA) was an outcome variable, p values and 
beta estimates reflect results of generalized estimating equations, health characteristics= diabetes, 
sleep apnea, hypertension, angina, heart failure, peripheral vascular disease, alcohol and drug 
abuse/dependence, and smoking. 
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Table 4.4. 
Depression and cognitive fUnctioning: The role of symptoms of insomnia 
Controlling for Insomnia, Age, Controlling for Insomnia, A ge, 
and Age 20 Cognitive Ability Age 20 Cognitive Ability, and 
Health Characteristics 
Cognitive Domains N Estimate SE p N Estimate SE p 
General Cognitive Ability 1143 -0.09 0.02 <.001 720 -0.08 0.02 <.001 
Processing Speed 1138 -0.02 0.02 .21 706 -0.04 0.03 .18 
Visual Spatial Processing 1076 -0.02 0.02 .31 * 710 -0.01 0.02 .52* 
Visual Spatial Memory 1138 -0.01 0.02 .52* 705 -0.01 0.03 .85* 
Verbal Memory 1136 -0.01 0.02 .59 703 -0.03 0.03 .29 
Verbal Memory Delay 1143 -0.02 0.02 .21 707 -0.03 0.02 .13 
Short Term Memory 1143 -0.02 0.01 .14* 710 ·-0.02 0.02 .45* 
Working Memory 1142 -0.05 0.02 .001 709 -0.05 0.02 .03 
Executive Functioning 1139 -0.05 0.02 .001 706 -0.06 0.02 .003 
Note. Insomnia symptoms= PSQI score, depression= CES-D score, age 20 cognitive 
ability= AFQT score at military induction, age 20 cognitive ability was not controlled for 
in the model when general cognitive ability (AFQT score in VETSA) was an outcome 
variable, p values and beta estimates reflect results of generalized estimating equations, 
health characterjstics= diabetes, sleep apnea, hypertension, angina, heart failure, 
peripheral vascular disease, alcohol and drug abuse/dependence, and smoking. The p 
values marked by "*" indicate that insomnia mediated the relation between these cognitive 
domains and depression, based on findings from a previous VETSA study (Franz et al. , 
submitted for publication) of the relation between depression and cognition without 
adjusting for insomnia. 
CHAPTER 5: Mechanisms by which insomnia impacts cognition: 
Insomnia X gene interaction and the role of cortisol and hippocampal volume 
Introduction 
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As described in Chapter 4, the literature is often conflicting regarding the relation 
between insomnia and cognitive functioning. While contradictory findings may reflect 
methodological limitations, inconsistencies may also be a function of the numerous 
factors that influence cognition and the interaction between these factors. Genes are 
involved in cognitive functioning, and studies have pointed to the relevance of gene 
interactions for elucidating the process of cognitive decline. An individual's genotype 
may influence the sensitivity to an environmental factor (gene X environment interaction) 
or to existing health factors (i.e., insomnia) on cognitive functioning. Numerous studies 
have demonstrated an interaction between specific genetic variants and 
environmental/health factors, such as having diabetes, exposure to lead and chemicals, 
and even breastfeeding, on cognitive funCtioning (Caspi et al., 2007; Froehlich et al. , 
2007; Johnson, Harris, Starr, Whalley, & Deary, 2008; Morales et al., 2008; Wang, Yuan, 
Prabhakar, Boswell, & Katz, 2006), suggesting that genes are unlikely to act 
independently. 
The apolipoprotein E gene 
The apolipoprotein E (apoE) gene is a major risk factor for Alzheimer's disease 
(AD) and is associated with cognitive impairment in nondemented older adults. The 
apoE gene exists in three isoforms: €2, €3, and €4. Individuals heterozygous for the €4 
allele are between 3 and 4 times more likely to be diagnosed with AD, and €4 
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homozygous individuals are between 10-12 times more likely (Small, Rosnick, 
Fratiglioni, & Backman, 2004). The apoE €4 allele is associated with hippocampal 
atrophy and the accumulation and production of beta amyloid plaques in AD, which is a 
central pathological marker of the disease (Juottonen, Lehtovirta, Helisalmi, Riekkinen, 
& Soininen, 1998). 
The literature provides mixed reviews on the extent to which apoE is related to 
impairments in cognitively normal aging individuals. For example, one study (Mayeux, 
Small, Tang, Tycko, & Stem, 2001) found that apoE was not associated with 
performance on any cognitive factors among participants age 65 and older. Interestingly, 
however, results point to an interaction effect of apoE and time, in which memory 
declined at a faster rate for individuals with the €4 allele. On the other hand, a fraternal 
twin study using twins discordant for apoE €4 demonstrated the influence of at least one 
€4 allele on cognition, such that twins with the €4 allele had a significantly lower mean 
performance (adjusted for education) on a battery of neuropsychological tests compared 
to their co-twins without the €4 allele (Reed et al. , 1994). Other studies have shown that 
the apoE €4 allele only affects specific cognitive constructs, including working memory, 
recall, and processing speed (Christensen, 2001; Reynolds et al. , 2006). A meta-analysis 
of the effects of apoE on cognition in aging described only small effects of the apoE €4 
allele in three cognitive domains: global cognitive functioning, episodic memory, and 
executive functioning, and found no effect on primary memory, attention, visual spatial 
skill, verbal ability, and perceptual speed (Small et al., 2004). 
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ApoE €4 has been found to impair the ability to cope with neurodegeneration. 
A poE affects neuronal plasticity through the transportation of lipid and cholesterol to 
neuronal sites undergoing remodeling (White, Nicoll, Roses, & Horsburgh, 2001 ). 
Studies have shown that while the €2 and €3 alleles enhance regeneration and sprouting, 
the €4 allele inhibits the outgrowth of neurites (Bellosta et al., 1995; Teter et al., 1999). 
Studies also associate the apoE €4 allele with deficits in recovering from or 
compensating for brain insult, including AD, head injury, or stroke (Kutner, Erlanger, 
Tsai, Jordan, & Relkin, 2000; Oitzl et al. , 1997; Teasdale, Nicoll, Murray, & Fiddes, 
1997). 
Insomnia as a brain insult: its relation with the hippocampus and cortisol 
Insomnia and structural brain changes. As described in Chapter 4, sleep 
problems are related to impairments in cognitive functioning. Several recent studies have 
examined structural brain differences among insomnia patients compared to controls, 
although results from these studies are largely inconsistent. Riemann and colleagues 
(2007) conducted a magnetic resonance imaging (MRI) pilot study examining brain 
volume in 8 patients with chronic primary insomnia and 8 good sleepers matched for age, 
sex, body mass index, and education. Patients with primary insomnia demonstrated 
significantly reduced hippocampal volumes bilaterally compared to the good sleepers, 
whereas amygdala, anterior cingulate, orbitofrontal and dorsolateral prefrontal cortex 
volumes did not significantly differ between groups. This is consistent with findings 
from animal studies suggesting that sleep deprivation impacts functional brain plasticity 
(Kopp, Longordo, Nicholson, & Luthi, 2006) and structural brain plasticity as 
demonstrated by reduced neurogenesis, especially in hippocampal regions (Guzman-
Marin et al. , 2005). 
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A second study aimed to replicate Riemann et al. 's results utilizing a larger 
sample size and failed to fmd a significant difference in hippocampal volume between 
primary insomniacs (n =:o 20) and controls (n = 15) (Winkelman et al. , 2010). Sleep 
problems were assessed through DSM-IV criteria, actigraphy, and the PSQI. Although 
there was no significant difference in hippocampal volume between insomniacs and 
controls on any of these measures, there was a correlation between poor sleep 
maintenance (measured through actigraphy) and hippocampal volume within the primary 
insomnia group. This has potential implications in aging populations since, as. described 
in Chapter 1, while younger people tend to have trouble falling asleep, older people have 
difficulty maintaining sleep (Rosekind, 1992). 
A third study was the first to use voxel-based morphometry, measuring gray and 
white matter volume among 24 insomnia patients and 13 matched controls (Altena, et al., 
2010). Insomnia patients had smaller gray matter volume in the left orbitofrontal cortex, 
the bilateral anterior precuneus of the parietal cortex, and the bilateral posterior 
precuneus in the occipitoparietal cortex, and there were no group differences in white 
matter volume. Further, reduced gray matter in the orbitofrontal cortex strongly 
correlated with insomnia severity. The orbitofrontal cortex is involved in emotion, 
decision-making, and problem-solving abilities, and the precuneus is involved in mental 
imagery and episodic memory retrieval. Altena et al.' s (20 1 0) findings of structural 
differences in the orbitofrontal cortex but not in the hippocampus among patients with 
insomnia compared to controls conflict with results from Reimann et al. (2007) and 
suggest that structural abnormalities in insomnia may extend beyond the hippocampus. 
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The role of cortisol. While some studies demonstrate structural brain changes 
among individuals with insomnia, it is unclear whether these differences are directly 
related to insomnia or to associated increased cortisol, or whether they predate the 
development of insomnia. Cortisol is a corticosteroid hormone produced by the adrenal 
cortex and is involved in response to stress and anxiety. Research has demonstrated that 
hypothalamic-pituitary-adrenal (HPA) axis hyperactivity, associated with increased 
cortisol levels, inhibits sleep and increases awakenings, and fragmented sleep increases 
HP A axis activity, creating a vicious cycle of dysfunction (Buckley & Schatzberg, 2005). 
The role of cortisol on hippocampal integrity had been clearly demonstrated; cortisol 
binds to receptors in hippocampal neurons and other brain regions, causing an alteration 
of calcium flux and glutamate uptake which may impair the ability of these neurons to 
withstand various metabolic stressors (Caselli et al. , 2002; Lupien et al., 2005). 
Findings from studies of healthy participants subjected to sleep restriction suggest 
a relationship between cortisol and sleep. One study subjected heaithy subjects without 
insomnia to three sleep conditions, normal sleep, partial sleep deprivation, and complete 
sleep deprivation, and found that in both sleep loss groups, alterations in cortisol were 
evident the evening following the night after sleep deprivation (Leproult, Copinschi, 
Buxton, & Van Cauter, 1997). While many sleep deprivation studies using healthy 
subjects support these findings (Chapotot, Buguet, Gronfier, & Brandenberger, 2001; von 
Treuer, Norman, & Armstrong, 1996; Weibel, Follenius, Spiegel, Ehrhart, & 
Brandenberger, 1995), others do not (Follenius, Brandenberger, Bandesapt, Libert, & 
Ehrhart, 1992; Seifritz et al., 1995), and potential longer term effects of acute sleep 
deprivation on cortisol are also unclear. Interestingly, evening cortisol levels while 
awake correlate with the number of awakenings during the subsequent night in subjects 
with and without insomnia (Rodenbeck & Hajak, 2001; Rodenbeck et al., 2002). 
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Another study (Vgontzas, Bixler, Wittman, et al., 2001) demonstrated that IV 
administration of cortisol releasing hormone in healthy men age-dependently increased 
nocturnal wake time and suppressed slow wave sleep, in which middle-age men 
compared to younger men showed higher sensitivity of sleep to the arousing effects of 
cortisol. Taken together, these findings may reflect the occurrence of a viscous cycle that 
may be responsible for the chronicity of insomnia. 
Surprisingly, there is a paucity of research examining the relation between cortisol 
and insomnia (as opposed to healthy participants subjected to sleep restriction). Sleep 
problems have been associated with elevated cortisol levels, even in patients with chronic 
insomnia who do not have depression or anxiety (Rodenbeck et al., 2002). A 
significantly larger amount of cortisol is secreted in patients with severe insomnia 
compared to individuals with less severe insomnia (Vgontzas, Bixler, Lin, et al., 2001), 
although there is conflicting evidence (Backhaus et al., 2006; Riemann et al., 2002; 
Varkevisser, Van Dongen, & Kerkhof, 2005). 
Cortisol is also associated with cognitive deficits in numerous domains, such as 
language, processing speed, hand-eye coordination, executive functioning, verbal 
memory and learning, and visual memory (ages 50-70) (Lee et al., 2007) and has been 
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found to modulate hippocampus-dependent declarative memory functions and declarative 
memory consolidation (Backhaus, et al., 2006; de Quervain, Roozendaal, Nitsch, 
McGaugh, & Hock, 2000; Het, Ramlow, & Wolf, 2005; Kirschbaum, Wolf, May, 
Wippich, & Hellhammer, 1996; Lupien et al., 1997). In a previous study ofVETSA 
participants, higher levels of area-under-the-curve (AU C) cortisol were significantly 
associated with poorer executive functioning, processing speed, and visual spatial 
memory performance (Franz, O'Brien, Hauger, Mendoza, Panizzon et al., unpublished 
manuscript). Franz and colleagues demonstrated that negative effects of cortisol are not 
specific to the hippocampus and are also associated with frontal-striatal systems, although 
the majority of cortisol research has focused on hippocampus related abilities. 
Increased cortisol levels are also associated with decreased hippocampal volume. 
One study examined 51 individuals (ages 60-87 years) and found higher levels of cortisol 
over a three to six year period to be associated with impaired memory and 14% lower 
hippocampal volume (Lupien et al., 2005). Deficits were found in declarative memory, 
immediate versus delayed memory, and spatial memory performance, which are 
associated with hippocampus functioning, but not in non-declarative memory, which is 
not associated with hippocampus integrity. 
No study to date has examined the role of cortisol in the relation between 
insomnia and hippocampal volume, although recent preliminary research has explored 
this issue. Animal research suggests that insomnia may directly contribute to changes in 
brain structure based on findings that sleep restriction or deprivation inhibits 
hippocampal neurogenesis in rats (Guzman-Marin, et al., 2005; Guzman-Marin et al., 
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2003; Guzman-Marin et al., 2006; Tung, Takase, Fornal, & Jacobs, 2005). On the other 
hand, one study of adult participants demonstrated that sleep deprivation in healthy 
subjects (as opposed to insomnia patients) inhibits neurogenesis in the hippocampus by 
elevating glucocorticoids, suggesting that cortisol might mediate the relation between 
insomnia and hippocampal volume (Mirescu, Peters, Noiman, & Gould, 2006). The 
present study was the first to examine whether cortisol mediates the relation between 
insomnia and hippocampal volume. 
Summary and hypotheses. Sleep problems, therefore, may be considered a type 
of neuronal insult, in part through its relationship with cortisol and the impact of cortisol 
on hippocampal integrity. As described above, since the €4 allele is associated with 
difficulty compensating for neural insult, €4 carriers may be more sensitive to the effects 
of insomnia on neuronal functioning. There may be an interaction effect, therefore, 
between insomnia and apoE status on cognition, which has not been previously 
examined. The relation between insomnia and cortisol and between insomnia and 
hippocampal volume is also examined in this chapter. Based on the literature, there 
should be a significant relation between insomnia and cortisol. Since findings regarding 
insomnia and hippocampal volume are mixed, this study builds upon existing literature 
and help to elucidate previous findings and to determine whether the association between 
insomnia and hippocampal volume is independent of cortisol. 
Methods 
Participants 
All participants were subjects from the Vietnam Era Twin Study of Aging 
(VETSA), described in Chapter 1. 
Cognitive Functioning 
The cognitive domains described in Chapter 4 will be examined in this chapter. 
Apolipoprotein E (APOE) 
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ApoE genotypes were determined using PCR conditions (Emi et al., 1988) and the 
Hhal restriction digest method (Hixson & Vernier, 1990) in the laboratory of Dr. 
Schellenberg at the Puget Sound VA Healthcare System. All genotypes were 
independently determined twice by laboratory personnel blind to the initial genotype and 
to the identity of the co-twin. Since there were only 27 participants who were 
homozygous for the €4 allele, apoE status was conceptualized as carriers (1 or 2 €4 
alleles) or non-carriers (no €4 allele). 345 participants had at least 1 €4 allele (29.8%), 
and 811 participants did not have an €4 allele (70.2%). There were 81 subjects with 
missing apoE genotype data. 
Cortisol 
Saliva collection. Saliva samples were obtained from all VETSA participants 
starting in late February 2005 (N=795); nine eligible twins declined participation in the 
cortisol data collection and saliva samples from 3 twins were lost or spilled (final 
N=783). In brief, the saliva collection protocol collected five saliva samples paralleling 
individual circadian patterns on two non-consecutive work days at home, two to three 
weeks prior to traveling to the test site. Five equivalent samples were collected on the 
day of testing. Two additional samples Gust prior to and immediately following lunch) 
were also collected on the day of in-lab testing. All saliva collection materials used by 
the participants that could come into contact with saliva (e.g., vials, gum, straws) were 
tested in advance to ensure they did not influence cortisol assay results. IRB approval 
was obtained at all sites, and all participants provided signed informed consent. 
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Participants were contacted in advance in order to individualize the saliva kit 
information and to set times on the reminder watches. Reminder calls ensured that 
instructions were understood and the kit placed by their bed for the morning sample. 
Participants were reminded to provide the awakening sample while they were still in bed 
and to not consume caffeine between the awakening and the awake-plus-30 minutes 
sample. If participants were acutely ill or experiencing unexpected stress, they were 
asked to call us to modify their schedule. The saliva kit included all supplies: labeled 4.5 
ml Cryotube spit vials, a pre-set reminder watch, a daily log, instructions, straws to 
facilitate drooling into each vial, Trident original sugarless gum (to be used only if 
needed), and a storage container with a track cap. J>articipants provided passive drool 
saliva samples according to their usual daily schedule corresponding to immediately upon 
awakening, 30 minutes after awakening, 1000 h, 1500 h, and bedtime. 
For the on-site testing, participants arrived the day before testing started and 
received their saliva kit supplies when they arrived at the hotel. As they did at home, on 
the test day twins provided samples as soon as they woke up, then half an hour after 
awakening. The 1000 h and 1500 h saliva samples were collected in the laboratory; the 
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bedtime samples were provided back at the hotel. Day of testing samples were collected 
between specific tests (close to 1000 hand 1500 h) rather than at exact times so that the 
collection of saliva samples was standardized across participants. Test day protocols 
were standardized across sites. Immediately following each saliva sample, participants 
completed a written log indicating their mood, food and drink intake, medications taken, 
alcohol use, and their activities during the previous hour. Saliva samples were shipped 
over-night to the University of California Davis to be assayed. 
Cortisol assays. Prior to conducting the assays, samples were centrifuged at 
3000 rpm for 20 minutes to separate the aqueous component from mucins and other 
suspended particles. Salivary concentrations of cortisol were estimated in duplicate using 
commercial radioimmunoassay kits (Siemens Medical Solutions Diagnostics, Los 
Angeles, CA). Of the possible 13,311 possible saliva samples from 783 participants, 149 
(1 %) samples were missing due to participant lapses or technical problems. Participants 
with more than one assay missing from a day were omitted from analyses (N=5). 
All samples from a participant were analyzed in the same assay batch; one to 
three individuals were included in the same assay batch. Batch numbers were retained in 
order to adjust for possible batch-specific effects. Cortisol assays were performed 
without knowledge of the zygosity of the participant. If salivary cortisol concentrations 
exceeded 50 nmol/L, the value was set to missing. This cut-point corresponds with 
research suggesting that values above 50 nmol/L are most likely outliers (Hellhammer, 
Wust, & Kudielka, 2009); in the VETSA sample, this value also corresponds with 
cortisol concentrations three standard deviations above the average awakening mean. 
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Scores were imputed for missing values only if the participant had no more than one 
missing value on a day. In order to impute missing data, the full samples' mean cortisol 
change between the time point was calculated with the missing value and the adjacent 
time point; for all time points except awakening, the time point prior to the missing value 
was used. The mean cortisol change for those two points was then added or subtracted 
from the individual participant's non-missing time point to get the imputed value for the 
missing time point iri question. For example, if a participant was missing a cortisol value 
for 1500 h, the full samples' mean change cortisol from 1000 h to 1500 h was calculated. 
This value was then subtracted from the participant's 1000 h value to obtain the 1500 h 
value. Cortisol values were natural log transformed prior to data analysis in order to 
normalize the distributions. 
Cortisol Indices. Two cortisol indices were created to reflect HP A axis 
dysregulation. The area-under-the curve (AUC) with respect to zero cortisol measure 
uses values from all five time points in a day and accounts for minor differences in the 
amount of time between cortisol samples by adjusting for the actual times of the cortisol 
samples. AUC cortisol is considered a measure of total hormonal output across the day 
(Pruessner, Kirschbaum, Meinlschmid, & Hellhammer, 2003). A second index was 
created to measure the amount of increase in cortisol from awakening to 30 minutes after 
awakening (when levels typically peak). This index is the cortisol awakening response 
(CAR) and is associated with the anticipation of stress, providing a measure of the 
reactivity capacity of the HPA axis (Doane et al., in press)). Total (three day) scores for 
AUC cortisol and CAR were created by averaging values across all three days. 
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Hippocampal volume 
Four hundred seventy four twins (202 pairs; 70 unpaired) of the 1237 total 
VETSA subjects participated in the MRI study. The MRI session was typically the day 
after the in-lab evaluation. Only 6% ofVETSA participants who were invited to undergo 
MRI declined to participate; 59% were included. The remaining participants were 
excluded from the MRI study for reasons such as possible metal in the body (7% ), 
claustrophobia (3%), unwillingness to travel to the MRI study sites (5%), scanner 
problems (8%), co-twin being excluded (9%), and other reasons. The demographic 
characteristics did not differ from the entire VETSA sample. 
Image acquisition. Images were acquired on Siemens 1.5 Telsa scanners at the 
University of California, San Diego and the Massachusetts General Hopsital. Images 
were automatically corrected for spatial distortion caused by gradient nonlinearity and B 1 
field inhomogeneity. 
Image processing. Volumetric segmentation was based on the publicly available 
FreeSurfer software package. The semi-automated, fully 3D whole-brain segmentation 
procedure uses a probalistic atlas and applies a Bayesian classification rule to assign a 
neuroanatomicallabel to each voxel (Fischl et al. , 2002; Fischl et al., 2004). FreeSurfer 
also provides an estimate of total intracranial volume (TIV) derived from the atlas scaling 
factor on the basis of the transformation of the full brain mask into atlas space (Buckner 




Generalized estimating equations (GEE) were implemented in SPSS to examine 
the interaction between insomnia and apoE genotype on cognition. GEE is described in 
more detail in Chapter 4. The separate cognitive domains were the outcome measures, 
and insomnia and apoE genotype were predictors. Insomnia was examined in two ways: 
using the PSQI score and using the dichotomized variable for insomnia. Age and early 
cognitive ability (AFQT at age 20) were included in the model as covariates. Health 
characteristics were added as covariates in the second model, including diabetes, sleep 
apnea, hypertension, angina, heart failure , peripheral vascular disease, alcohol and drug 
abuse/dependence, and smoking. In the first step ofthe interaction analysis, the 
predictors were insomnia (either PSQI score or dichotomous variable) and apoE 
genotype, and in the second step, the interaction of insomnia by apoE genotype was 
added to the predictors. Beta weights quantify the influence Of each predictor. 
Generalized estimating equations were also utilized to examine the relation 
between insomnia (continuous and dichotomous) · and cortisol, with and without adjusting 
for symptoms of depression (CES-D score). Finally, GEE was used to examine the 
relation between insomnia (continuous and dichotomous) and hippocampal volume. 
Several increasingly complex models were performed. The first model adjusted for age 
and total intracranial volume (TIV), the second model adjusted for age, TIV, and 
depression, and the third model adjusted for age, TIV, depression, and cortisol. 
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Results 
Insomnia X apoE interaction 
The main effects of insomnia (PSQI score and dichotomized variable) are 
presented in Chapter 4. Table 5.1 shows the beta weights and p values forth~ €4 main 
effects and interaction effects after adjusting for age and AFQT score at induction. There 
was no significant relationship between apoE genotype and any of the cognitive domains. 
In the next step, the interaction of insomnia and apoE was not significant for any 
cognitive domain. Analyses were also conducted without controlling for any covariates 
and after controlling for depression, cortisol, and additional health characteristics 
described in Chapter 4, and the interaction of insomnia and apoE on the nine cognitive 
domains remained non-significant (data not shown). Results also remained the same 
when examining €4 homozygotes compared to non-carriers (data not shown). Figures 
5.1 A-I display the interaction models ofPSQI score and apoE genotype on general 
cognitive ability, processing speed, visual spatial processing, visual spatial memory, 
verbal memory, verbal memory delay, short term memory, working memory, and 
executive functioning, respectively. Upon visual inspection of the results, the negative 
slopes of the relationship between PSQI score and cognitive performance appear to be 
steeper among €4 carriers compared to non-carriers for general cognitive ability, visual 
spatial processing, verbal memory, verbal memory delay, and working memory but not 
for processing speed, visual spatial memory, short term memory, and executive 
functioning. 
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Insomnia and cortisol 
The unadjusted correlation between symptoms of insomnia (PSQI score) and 
AUC cortisol was not significant (r = .027; p= .50), and the correlation between 
symptoms of insomnia (PSQI score) and CAR was not significant (r = -.014, p=.714). 
Among people without insomnia (PSQI score < 6), the mean AUC cortisol was 22.76 (sd 
5.63), and among people with insomnia (PSQI score > 6), AUC was 22.82 (sd 5.86). 
Among people without insomnia, the mean CAR was 1.21 (sd .34), and among people 
with insomnia, the mean CAR was 1.20 (sd .38). Table 5.2 shows results for the 
generalized estimating equations with insomnia (PSQI score and dichotomous variable) 
as the predictor and AUC and CAR as outcome variables. The effect of insomnia on 
cortisol was not significant in all models. As a follow-up analysis, cortisol (AUC and 
CAR) was treated as a predictor and insomnia (continuous and dichotomous) was treated 
as an outcome variable. There was also no significant effect of cortisol on insomnia (data 
not shown).· Of note, depression (CES-D score) was significantly related to AUC cortisol 
after adjusting for PSQI score (B=.42, SE=.l8, p=.02) and after adjusting for the 
dichotomized insomnia variable (B=.39, SE=.l7, p=.03) but was not related to CAR 
cortisol even before adjusting for insomnia. 
Insomnia and hippocampal volume 
The unadjusted correlation between the left hippocampus and insomnia (PSQI 
score) was significant (r = -.128, p=.006), and the unadjusted correlation between the 
right hippocampus and insomnia (PSQI score) was significant (r = -.127, p=.006). The 
left and right hippocampus were strongly correlated (r = .812; p<.OOl). Among people 
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without insomnia, mean left hippocampal volume was 4019.67 mm3 (sd 360.28 mm3), 
and among people with insomnia, mean left hippocampal volume was 3971 .27 mm3 (sd 
415.80 mm3) . Among people without insomnia, mean right hippocampal volume was 
4261.56 mm3 (sd 405.80 mm3) , and among people with insomnia, mean right 
hippocampal volume was 4190.53 mm3 (sd 462.45 mm3). 
Table 5.3 shows results for the generalized estimating equations with insomnia 
(continuous and dichotomous variables) as a predictor and hippocampus volume (left and 
right) as outcome variables after controlling for potential confounders. The PSQI score 
significantly predicted hippocampal volume bilaterally. The dichotomous insomnia 
variable only significantly predicted right hippocampal volume after adjusting for age, 
intracranial volume, and depression but not after adjusting for cortisol. The dichotomous 
variable did not significantly predict left hippocampal volume. 
Discussion 
Insomnia X apoE interaction 
Since the apoE €4 allele is associated with difficulty in compensating for 
neuronal insult, it was hypothesized that there would be an interaction between insomnia 
and apoE genotype on cognitive functioning. Results suggest that the effect of insomnia 
on cognitive performance is not influenced by the apoE genotype in middle-age men 
(mean age= 55.6), as there was no significant difference between €4 carriers and non-
carriers in the slope of the relation between PSQI and cognitive domain scores. While 
these results were not statistically significant, there appeared to be a trend towards an 
interaction for general cognitive ability, working memory, verbal memory, verbal 
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memory delay, and visual spatial processing. For these cognitive domains, the slope of 
the relation between PSQI score and cognition was steeper among €4 carriers compared 
to non-carriers, and the regression lines clearly intersected (Figure 5.1). The non-
significant results may reflect the enormous variability in cognitive performance, 
resulting in insufficient power to detect significant differences in slope. 
Trends in the data may have meaningful implications for individuals at risk for 
Alzheimer's disease (AD). It is interesting that for the majority of the memory domains, 
there was a stronger relation (i.e., steeper negative slope) between insomnia and memory 
performance among €4 carriers compared to non-carriers. Since memory substrates are 
affected earliest in Alzheimer's disease, these results could reflect very preclinical signs 
of AD. Participants in this study are, on average, slightly younger than the age at which 
cognitive decline in aging is typically first observed (Finket et al. , 2003). Furthermore, 
while research has demonstrated the effects of apoE on cognition over time, apoE was 
not found to impact cognition in a sample of individuals in their mid 60's (Mayeuz et al. , 
2001). Given the age of this sample, a significant interaction may not have been detected 
since the majority of subjects may be able to compensate for the potential impact of the 
apoE genotype on cognition. The longitudinal nature of this study will allow for further 
investigation when subjects are approximately six years older, and trends in these initial 
results may reach statistical significance over time. For individuals susceptible to AD 
(i.e., apoE €4 carriers), memory decline may be induced by sleep problems, possibly 
creating a diurnal pattern in symptoms, and it is therefore important to study the relation 
between apoE and insomnia over time. 
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This is the first study to date to examine whether insomnia differentially impairs 
cognition based on apoE status. One previous study investigated the interaction between 
daytime somnolence (using the Epiworth Sleepiness Scale; ESS) and apoE on cognition 
in cognitively normal individuals (age 30-70) (Caselli et al., 2002). Results of the present 
study are largely consistent with Caselli et al. 's (2002) findings . Caselli and colleagues 
(2002) reported that for €4 homozygous individuals, performance on eleven cognitive 
measures declined as sleepiness scores increased. For individuals with no €4 allele, 
however, sleepiness did not have a significant effect on cognitive performance, except on 
one measure of visual memory. The interactions that reached statistical significance were 
between sleepiness and apoE on two measures of delayed verbal memory. 
Caselli et al. 's (2002) finding of a significant relation between sleepiness and 
visual memory among non-carriers is not surprising given results from Chapter 4. As 
described in the previous chapter, visual memory is most strongly associated with 
insomnia and therefore may be impacted by insomnia regardless of genetic 
vulnerabilities. In fact, in the present study, non-carriers have a slightly more negative 
slope of the relation between PSQI score and visual memory performance compared to 
€4 carriers. 
Insomnia, cortisol, and hippocampal volume 
The neurodegenerative mechanisms by which insomnia impacts cognitive 
functioning were explored in the second part of this study. Previous literature has 
demonstrated a relation between sleep and cortisol and the role of excess cortisol on 
neuronal damage in the hippocampus. It was hypothesized, therefore, that insomnia may 
be conceptualized as type of brain insult partly through its relation with cortisol and 
consequent impact on hippocampal integrity. 
97 
Contrary to what was predicted, there was no association between insomnia and 
AUC or CAR cortisol measures. Six studies have previously examined increased cortisol 
among patients with insomnia (compared to normal sleepers under sleep restriction 
conditions), in which three have found significant differences in cortisol between patients 
and controls (Rodenbeck & Hajak, 2001; Vgontzas, Bixler, Lin, et al., 2001; Vgontzas et 
al., 1998) and three have not (Backhaus et al., 2006; Riemann et al., 2002; Varkevisser, 
Van Dongen, & Kerkhof, 2005). Methodological differences might account for 
conflicting results. The majority of studies to date have measured cortisol through blood 
samples (Backhaus et al., 2006; Riemann et al., 2002; Rodenbeck & Hajak, 2001; 
Vgontzas, Bixler, Lin et al., 2001), with one that measured urinary free cortisol 
(V gontzas et al., 1998) and one that measured free cortisol through saliva samples 
(Varkevisser, Van Dongen, & Kerkhof, 2005). Moreover, all previous studies were 
conducted in a laboratory setting where participants slept overnight, and many only 
examined nocturnal cortisol secretion (Backhaus et al., 2006; Riemann et al. , 2002; 
Rodenbeck & Hajak, 2001), in which blood samples were obtained through a catheter 
placed in subjects' veins while participants were sleeping. Two studies examined 24 hour 
(including while asleep) cortisol levels (V gontzas, Bixler, Lin, et al., 2001; V gontzas, et 
al., 1998), and one measured cortisol only when subjects were awake (Varkevisser et al., 
2005). The methods ofVarkevisser and colleagues' (2005) study, who also reported no 
relationship between insomnia and cortisol, are most similar to this study, in that both 
examined salivary cortisol when subjects were awake. Cortisol was measured during 
sleep in all studies that demonstrated increased cortisol among insomnia patients, 
suggesting that increased cortisol secretion among patients with insomnia may be 
specifically related to sleep states. 
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The present study only utilized a subjective measure of insomnia, whereas all 
previous studies also examined objective sleep disturbances. Interestingly, Riemann et 
al. (2002), who did not find differences in cortisol between groups, reported that primary 
insomniacs (fulfilling DSM-IV diagnostic criteria) did not demonstrate objective 
differences in sleep, measured by polysomnography, compared to the control group 
during three nights of sleep in a laboratory. There were significant differences, however, 
on the PSQI score between individuals with and without insomnia. Based on these 
findings, it is possible that there were no objective differences in sleep patterns in the 
VETSA sample, which might explain a lack of association between subjective sleep 
problems and cortisol. Objective measures of sleep were not examined, which is a 
limitation to this study. On the other hand, Backhaus et al. (2006) also failed to 
demonstrate differences in cortisol levels between primary insomniacs and controls, yet 
they found objective sleep differences (measured through EEG) and significant 
differences in the PSQI score between groups. 
A major strength of this study is that it is by far the largest study to date of 
insomnia and cortisol, examining 657 participants with complete PSQI and AUC cortisol 
data and 725 participants with complete PSQI and CAR data. The next largest study 
examined 16 participants with primary insomnia and 13 control subjects (Backhaus et al., 
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2006). This study, therefore, substantially contributes to the literature, and future studies 
utilizing larger sample sizes should examine nocturnal cortisol levels. 
Results of this study also elucidate conflicting findings on the relation between 
insomnia and hippocampal volume by dramatically increasing the sample size. The 
largest structural neuroimaging study to date examined 24 insomnia patients and 13 
controls (Altena et al., 2010), and this study examined 460 subjects with complete PSQI 
and structural neuroimaging data. Results of the present study suggest a strong relation 
between symptoms of insomnia and hippocampal volume, independent of cortisol and 
other confounders. 
Riemann et al. (2007) conducted the first study of brain volume among patients 
with insomnia compared to controls and reported a significant difference between groups, 
whereas Winkelman et al. (20 1 0) failed to replicate these findings . It is possible that the 
mean age of participants influenced results since hippocampal volume differences were 
not detected in younger subjects. The mean age of participants in Winkelman et al. 
(2010), Riemann et al. (2007), and the present study was 39.3 (sd 8.7), 48.4 (sd 16.3), and 
55.6 (sd 2.5), respectively. 
The PSQI score, which reflects a continuum of severity of insomnia-related sleep 
problems, was significantly associated with hippocampal volume in all models, whereas 
the dichotomous variable was only related to right hippocampal volume. This finding 
may reflect differences in statistical power when examining continuous versus 
dichotomous variables. Previous studies examined the relation between brain volume 
and categorical DSM diagnosis of insomnia, which might explain Altena et al. and 
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Winkelman et al.'s findings ofno relationship between insomnia and hippocampal 
volume. Furthermore, spatial tasks are associated with right hemisphere areas, whereas 
verbal memory is associated with left hemisphere areas, and a stronger association 
between insomnia and decreased right hippocampal volume is consistent with poorer 
performance on visual spatial domains discussed in Chapter 4. 
Results from this study of a strong relation between symptoms of insomnia and 
hippocampal volume are consistent with previous literature on insomnia and deficits in 
declarative memory consolidation (Backhaus et al., 2006; Nissen et al., 2006) and with 
findings from Chapter 4 on the relationship between insomnia and poorer performance on 
numerous memory domains. While the present study focused only on the hippocampus 
and sought to elucidate the relation between insomnia, cortisol, and hippocampal volume, 
future research should focus on the relation between insomnia and other brai.n regions. 
Results from Chapter 4 of a robust relationship between insomnia and visual spatial 
deficits, coupled with Altena et al. ' s (20 1 0) results of lower precuneus volume among 
patients with insomnia, suggests that future research should particularly focus on the role 
of insomnia on the precuneus. Understanding the mechanisms by which insomnia is 
related to the precuneus may have implications for preventing or treating cognitive 
decline. 
Contrary to what was predicted, cortisol did not account for the relation between 
insomnia and hippocampal volume. The mechanism by which insomnia impacts 
neuronal integrity, therefore, should be explored in future studies. As described above, 
some research suggests a direct relationship between insomnia and hippocampal 
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functioning demonstrated by animal studies of sleep deprivation and restriction on 
hippcomapal neurogenesis (Guzman-Marin et al., 2005). These findings support the 
hypothesis that sleep itself might be necessary for neuronal regeneration in hippocampal 
structures. 
Future studies should also address whether lower hippocampal volume precedes 
or causes the development of insomnia. This can be explored through co-twin control 
studies by examining identical twins that are discordant for insomnia. Lower 
hippocampal volume among healthy co-twins compared to a control group (i.e., subjects 
who do not have insomnia and whose twins do not have insomnia) might suggest that 
structural brain differences precede insomnia. 
In sum, this study demonstrated that insomnia acts as a brain insult due to its 
association with reduced hippocampal volume, and these findings are consistent with 
cognitive impairments observed in insomnia patients. The lack of an association with 
cortisol suggests that future research should focus on the mechanisms by which insomnia 
is related to hippocampal volume. While there were no significant interaction effects 
between insomnia and apoE on cognitive functioning, it is possible that such interactions 
may emerge as subjects age. 
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Table 5.1. 
The interaction between apoE and insomnia on cognitive functioning. 
e4 Main Effects e4 X PSQI Score e4 X Dichotomized 
Insomnia 
N Estimate {SE) p value N Estimate (SE) p value Estimate (SE) p value 
AFQT Percentile 1155 -0.04 (.04) .35 1116 0.06 (.06) .36 -0.03 (.09) .77 
Processing Speed 1133 0.08 (.05) .08 1110 -0.03 (.07) .67 0.05 (.10) .65 
Visual Spatial Processing 1138 -0.007 (.04) .87 1116 -0.008 (.06) .89 -0.07 (.09) .42 
Visual Spatial Meroory 1133 0.02 (.05) .63 1110 -0.08 (.07) .23 0.07 (.II} .53 
Verbal Merrory 1130 -0.03 (.05) .58 1107 0.06 (.07) .40 -0.008 (.II} .94 
Verbal M emory Delay 1139 -0.06 (.04) .22 1116 0.04 (.06) .53 -0.03 (.10) .77 
Short Term Memory 1138 -0.03 (.04) .48 1115 -0.05 (.06) .41 0.02 (.09) .86 
Working Memory 1137 -0.07 (.04) .12 1114 0.05 (.06) .44 -0.13 (.09) .17 
Executive Functioning 1134 -0.04 (.04) .35 1111 -0.03 (.06) .62 0.07 (.09) .46 
Note. Age 20 cognitive ability (AFQT score at military induction) and age were included 
in the model as covariates, age 20 cognitive ability was not controlled for in the model 
when general cognitive ability (AFQT score in VETSA) was an outcome variable, p 
values and beta estimates reflect results of generalized estimating equations, SE= 
standard error. 
Table 5.2. 
Relation between insomnia and cortisol. 
PSQI Score Dichotomized Insomnia 



























Note. The main effects of insomnia (using the continuous PSQI score and the 
dichotomized variable) on area under the curve (AUC) cortisol and cortisol awakening 
response (CAR), with and without adjusting for depression (score on the CES-D) are 
presented, p values and beta estimates reflect results of generalized estimating equations, 
SE= standard error. 
Table 5.3. 
Relation between insomnia and hippocampal volume. 
PSQI Score 
N Estimate (SE) 
Adjusting for age and intracranial volume 
Right Hippocampus 460 
Left Hippocampus 460 
-70.62 (21.40) 
-63 .03 (18.92) 
Adjusting for age, intracranial volume, and depression 
Right Hippocampus 444 








Adjusting for age, intracranial volume, depression, and cortisol 
Right Hippocampus 331 





















Note. The main effects of insomnia (using the continuous PSQI score and the 
dichotomized variable) on left and right hippocampal volume are presented. Three 
increasingly complex models were performed; the first adjusting for age and intracranial 
volume, second, additionally adjusting for depression, and third, additionally adjusting for 
cortisol (both AUC and CAR), p values and beta estimates reflect results of generalized 
estimating equations, SE= standard error. 
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Figure 5.1 A-1. 
Interaction models for PSQI score and apoE genotype on cognitive functioning. 
Figures A-I display results for general cognitive ability, processing speed, visual spatial 
processing, visual spatial memory, verbal memory, verbal memory delay, short term 
memory, working memory, and executive functioning, respectively. ApoE €4 carriers 
are presented in green and apoE €4 non-carriers are presented in blue. The PSQI score is 
on the X axis and the specific cognitive domain is on the Y axis. 
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CHAPTER 6: Integrated Discussion 
The Vietnam Era Twin Study of Aging (VETSA) is a large-scale longitudinal 
study that investigates the relative contributions of genes and the environment to age-
related changes in a broad range of phenotypes. This dissertation utilized wave one 
VETSA data and focused on two outcomes known to change with age: the development 
of insomnia and impairments in cognitive functioning. 
The series of studies described in this dissertation examined insomnia from a 
neurobiological perspective and utilized classic twin analyses, neuropsychological 
methods, hormone and genotype data, and structural MRI to explore the etiology of 
insomnia, the relationship between insomnia and depression, and the mechanisms 
through which insomnia impacts cognitive decline (i.e., the role of depression, cortisol, 
hippocampal volume, and the apoE gene) . 
The first study employed twin methods to examine the genetic and environmental 
influences on insomnia. Results demonstrate that approximately 34% of the variability of 
insomnia is due to additive genetic effects and 66% of the variability is due to the non-
shared environment. The shared family environment did not significantly contribute to 
the variability of insomnia. The genetic and environmental influences on component 
scores ofthe PSQI, reflecting individual symptoms of insomnia, were also examined. 
Models that included additive genes and the non-shared environment were the best fit for 
all component scores with the exception of medication use and sleep disturbances, which 
were not influenced by additive genetic effects. These results build upon existing 
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literature by using a more comprehensive assessment of sleep problems that more closely 
reflects the diagnostic criteria for insomnia. 
The second study also utilized twin methods and focused on the nature of the 
relationship between insomnia and depression, as these disorders often co-occur. This 
study was the first investigation of the extent to which insomnia and depression share a 
single genetic liability or independent liabilities. Results demonstrate that much of the 
same genetic influences on the variability of insomnia are also associated with 
depression, suggesting that the comorbidity between these two disorders is in part due to 
common genetic effects. When controlling for questions about sleep problems in the 
assessment of depression, these findings remained the same. 
The third study examined the impact of insomnia on cognitive functioning and the 
interrelationship between inso:rimia, depression, and cognition. Insomnia was 
significantly related to poorer performance on tests of general cognitive ability, visual 
spatial processing, visual spatial memory, short term memory, and working memory. 
After adjusting for depression, insomnia was significantly related to visual spatial 
processing and memory, suggesting that insomnia independently influences visual spatial 
abilities. Further, insomnia mediated the relationship between depression and visual 
spatial processing, visual spatial memory, and short term memory. 
The fourth study explored the impact of insomnia on neural integrity by 
examining its relation with hippocampal volume via cortisol, which has not been 
examined previously. Insomnia was significantly related to lower hippocampal volume, 
and there was no association between insomnia and cortisol levels, suggesting that 
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insomnia may be directly related to lower hippocampal volume. This study also 
examined the interaction between insomnia and apoE genotype on cognitive functioning 
since apoE is related to deficits in recovering from neuronal insult. While insomnia did 
not differentially impact cognition based on apoE genotype, trends towards interactions 
were observed, particularly in memory domains . 
These findings have implications for the treatment of insomnia and depression 
and may inform prevention and intervention techniques related to cognitive preservation 
in aging. For example, since the genetic influences on insomnia and depression are, in 
part, correlated, future research should explore possible endophenotypes (which are more 
closely related to genetic liability) that influence the development of both disorders. 
Targeting potential endophenotypes in treatment may lead to improvements in both 
disorders . Previous research has demonstrated that increased cortisol secretion is an 
endophenotype of depression (Vinberg et al. , 2008; Wichers et al., 2008) and may be a 
candidate endophenotype of insomnia. Findings from this study, however, suggest that 
cortisol may not underlie the development of insomnia. Future research should focus on 
other common liabilities, such as personality traits. Of note, this study only examined 
cortisol levels throughout the day, and nocturnal cortisol levels should be explored 
further. 
Understanding the effect of insomnia on cognitive functioning may lead to more 
specific targets for cognitive preservation. This study attempted to clarify conflicting 
results from previous studies, as there is little evidence of a single and consistently 
reported cognitive deficit in insomnia patients (Fulda & Schulz, 2001 ; Shekleton et al., 
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2010). The strong relation between insomnia and visual spatial processing and memory 
deficits, after controlling for depression and other confounders, has significant 
implications for older individuals, since visual perceptual processing is one of the most 
prominent impairments in cognitive functioning among older adults (Walsh, 1988). 
Treating insomnia and related sleep problems might be an appropriate and successful 
intervention for older individuals who demonstrate visual spatial memory and processing 
impairments. Furthermore, research has demonstrated that hippocampal activity 
expressed during slow wave sleep (SWS) is associated with spatial learning (Peigneux et 
al., 2004), suggesting that focusing on decreasing sleep onset latency to impact SWS 
might have the greatest impact in treatment. 
The association between hippocampal volume and insomnia supports 
neuropsychological results of the relation between insomnia and poorer performance on 
memory tasks, including visual spatial memory, short term memory, and working 
memory. Since cortisol did not explain the relation between insomnia and hippocampal 
volume, insomnia may directly impair neuronal integrity in the hippocampus, although 
further research on this neurodegenerative process is needed. Trends demonstrating that 
apoE €4 carriers have more difficulty in compensating for insomnia-related hippocampal 
insult compared to non-carriers may have implications for individuals at risk for 
Alzheimer's disease (AD). Memory substrates are affected earliest in Alzheimer's 
disease, and these results could reflect very preclinical signs of the disease. For 
individuals susceptible to AD (i.e., apoE €4 carriers), memory decline may be induced 
by sleep problems, possibly creating a diurnal pattern in symptoms, and it is therefore 
important to study the relation between apoE and insomnia over time. 
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Since insomnia was most strongly related to visual spatial abilities, further 
examination of brain regions including the precuneus, inferior and superior parietal 
cortex, and posterior parieto-occipital cortex, which are linked to visual spatial 
functioning (Diekmann et al., 2009; Ng et al., 2001; Stylianou-Korsnes et al., 2010), 
should be explored in VETSA. One previous study demonstrated a relation between 
insomnia and decreased precuneus volume, and this fmding should be replicated using 
the VETSA sample, which is unique given the extremely large sample size relative to 
previous structural neuroimaging studies. 
Until recently, insomnia was mainly conceptualized as a psychological disorder 
caused by psychosocial stress and maintained by maladaptive behaviors (Riemann et al. , 
2009). This study supports the conceptualization of insomnia as a psychobiological 
disorder that is also influenced by additive genes and .accompanied by 
neuropsychological deficits and structural brain alterations. 
This study used baseline data of a longitudinal study of aging (VETSA) and sets 
the stage for future research on the causes and consequences of insomnia and aging. 
Since the prevalence of insomnia increases with age and is associated with numerous 
negative outcomes, future VETSA studies should focus on the changes in genetic and 
environmental influences on insomnia and its relation with depression, and the impact of 
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